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ABSTRACT 
 
Shigellosis, a severe form of bacillary dysentery, is primarily caused by the gram 
negative pathogen, Shigella flexneri.  In order to elicit disease, the pathogen must 
pass through the digestive tract and induce its uptake by colonic epithelial cells.  To 
facilitate this process, S. flexneri uses a type III secretion system (TTSS) to form a 
pore in host cell membranes and deliver translocator and effector proteins to the 
targeted host cells.  Translocon pore formation is the responsibility of the invasion 
plasmid antigens IpaB and IpaC.  Prior to their secretion, IpaB and IpaC are stored in 
the bacterial cytoplasm where they individually associate with the molecular 
chaperone IpgC.  In this study, a variety of biophysical and molecular techniques 
were utilized to investigate the structural and functional characteristics of these 
proteins and the interactions of the translocator/chaperone and the 
translocator/translocator complexes.    
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CHAPTER 1  
Introduction 
 
Diarrheal diseases affect billions of people worldwide each year.  Shigellosis, 
a severe form of bacillary dysentery, is caused by the gram negative bacillus, Shigella 
flexneri and its close Shigella relatives.  Although, most cases of shigellosis are due to 
endemic infections by S. flexneri in developing regions, approximately 20,000 cases 
are reported in the US each year and this rate of incidence may be significantly under-
estimated.  Additionally, increasing antibiotic resistance has compounded the need for 
research into vaccine development for this pathogen. 
 
Historical Perspective 
 The etiological agent of bacillary dysentery was first described by Kiyoshi 
Shiga during the 1897 sekiri outbreaks in Japan.  During the observation of 36 
dysentery patients, bacilli were isolated from the stool of the patients and found to 
cause similar symptoms in dogs when introduced orally (Shiga 1897).  In subsequent 
years, Shiga continued to characterize the organism and eventually named it Bacillus 
dysenteriae (Shiga, 1897).   
In the years following Shiga’s initial observation of Bacillus dysenteriae, 
many investigators worked to characterize the organism.  Several investigators began 
to report and characterize organisms that demonstrated similar disease and that were 
morphologically and biochemically comparable to the organism described by Shiga 
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(Flexner 1900, Kruse 1900).   By 1952, the Congress of the International Association 
of Microbiologists (Shigella Commission) officially adopted the current genetic name 
Shigella, in honor of Shiga’s work with the organism.  The genus Shigella belongs to 
the family Enterobacteriaceae and has grown to include four species, S. boydi, S. 
dysenteriae, S. flexneri and S. sonnei. 
After the 1950’s, emphasis grew on defining and characterizing the 
mechanism of virulence in Shigella.  Although shigellosis is limited in host range to 
humans and other high primates, animal models began to emerge in the 1950’s and 
1960’s beginning with the adaptation of Shigella infection to the corneal epithelium 
of guinea pigs (Sereńy test) (Sereńy 1957).  Soon after, it was demonstrated that 
Shigella could be grown in cultured mammalian cells (Gerber and Watkins 1961).  
More recently, high doses have been found to induce pneumonia and diarrhea in rats 
if introduced nasally or rectally, respectively (Mallet et al., 1993) (Kamgang et al., 
2005).   
Until 1964, it was believed that the pathogenicity of Shigella was due 
primarily to the release of bacterial toxins while the pathogen adhered to the surface 
of intestinal epithelial cells (Watkins, 1960).  Work by LaBrec et al. demonstrated 
that feeding virulent strains S. flexneri to guinea pigs resulted in the ulceration, and 
penetration of the epithelial cells of the colon and lamina propia, establishing that 
invasion of the colonic epithelium was an essential aspect of the disease (LaBrec et 
al., 1964). 
 3 
The genetic basis for Shigella pathogenesis was not determined until the 
1980’s.  Sansonetti and colleagues discovered that S. sonnei and S. flexneri virulence 
was dependent upon the presence of a large plasmid.  Loss of this plasmid resulted in 
the inability of the organism to invade mammalian cells in culture or evoke 
keratoconjuctivitis in guinea pigs (Sansonetti 1981, Sansonetti 1982).  Eventually, it 
was established that all Shigella species possess a large (200 kDa), low-copy number 
virulence plasmid containing genes essential for cellular invasion.  Much of the 
current work on Shigella continues to work toward characterizing and understanding 
the genes and proteins encoded on this plasmid. 
 
Epidemiology and Pathology 
 Bacillary dysentery, or shigellosis, is primarily a disease of humans and other 
higher primates which is largely limited to the intestinal mucosa.  Symptoms typical 
of shigellosis are watery diarrhea with mucus, fever, malaise, and abdominal 
cramping.  The severity and range of symptoms may be dependent upon the number 
of organisms ingested and species.  Disease can be further complicated by septicemia, 
hypoglycemia, bacteremia, dehydration, uremic and hemolytic syndrome and toxic 
megacolon (Phalipon and Sansonetti, 2007).    
 Shigella is responsible for more than 150 million cases of bacillary dysentery 
worldwide each year, which ultimately results in more than one million deaths 
(Hueck 1998) (Kotloff et al., 1999) (Venkatesan 2001).  The incidence of fatality is 
higher in children under the age of five due to complications that result from 
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dehydration and malnutrition.  S. flexneri is the most common species encountered in 
endemic areas, while S. sonnei is more prevalent in industrialized nations.   
 Shigella infection is acquired via the fecal-oral route and epidemics of the 
organism are clearly associated with poor hygienic practices and contaminated food 
and water sources (DuPont 1989).  In the United States, outbreaks are generally 
associated with child care facilities, community homes and prisons.  Additionally, 
homosexual men are more susceptible to shigellosis and reoccurring cases have been 
found to cause complications when associated with AIDS (Blesser et al., 1989).  In 
developing nations, crowding and sewage contamination of water supplies commonly 
lead to Shigella outbreaks in the general population.  Most often infections are 
associated with S. flexneri, but epidemic outbreaks are generally traceable to S. 
dysenteriae.  The latter organism is most often associated with fatal cases of 
shigellosis due to the synthesis of a potent exotoxin (Shiga toxin) (O’Brien et al., 
1980).   
The organism enters the host orally and travels through the digestive system 
until it reaches the large intestine.  Invasion of the intestinal epithelium by Shigella 
cannot occur via the apical side of the mucosal epithelial cells, so the organism must 
first make its way to the basal face of the epithelium to initiate invasion.  Thus, upon 
reaching the large intestine, Shigella is taken up in vacuoles by microfold cells (M 
cells) in the colon (Owen 1986) (Wasset 1989).  The organism escapes from the 
vacuole and eventually travels to underlying macrophages that are associated with M 
cell-associated lymphoid follicles (Sansonetti et al., 1996).  The organism is taken up 
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by the phagocyte, which then induces apoptosis which results in the escape of the 
pathogen to the basal side of the colonic epithelium.  Death of the macrophage results 
in the release of IL-1β.  This proinflammatory cytokine eventually results in the 
recruitment of PMN cells to site of infection and the onset of inflammation 
(Zychlinsky et al., 1994) (Sansonetti et al., 2000).  Meanwhile, the bacteria induce 
their own uptake into colonic epithelial cells and spread laterally through the cells of 
the epithelium by a process known as actin based motility (ABM) (Mounier 1992).  
Ultimately, it is the cells of the host’s immune system that cause inflammation and 
ulceration of the mucosa to the colon and the symptoms associated with shigellosis 
(Wassef 1989) (Islam 1997).   
 
The pathogen 
Shigella belongs to the tribe Escherichieae, which are members of the family 
Enterobacteriaceae.  Like other pathogens of this family, Shigella is a gram-negative 
gastrointestinal pathogen, primarily responsible for disease in humans and primates.  
Like other organisms belonging to this family, Shigella is facultatively anaerobic, 
oxidase negative and possesses the abilities to reduce nitrate and ferment glucose.  
Differentiation among the species can be accomplished biochemically by testing for 
ornithine decarboxylation and mannitol and xylose fermentation (Kreig, 1984).  
Additionally, species identification can be determined serologically, as all species 
possess species-specific O-antigen components (Kreig, 1984).      
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Shigellosis is highly contagious and infectious, requiring relatively few 
organisms to elicit disease (10-100 organisms) (DuPont, 1989).  Infection is generally 
associated with poor sanitation and outbreaks are usually linked to a contaminated 
food or water source.  The disease is generally self limiting (symptoms usually last 5-
7 days) and is routinely treated with oral antibiotics (Hueck, 1998).  Currently, oral 
antibiotics are the preferable means of treatment; however, emerging antibiotic 
resistance is limiting the number of drugs available for the treatment of shigellosis.  
Strains resistant to tetracycline, sulfonamides, ampicillin and trimethoprim-
sulfamethoxazole have been found worldwide (Hueck, 1998). 
 
Genetic Determinants of Virulence 
 The virulence of Shigella is dependent upon a number of genes located on 
pathogenicity islands found in both the chromosome and on a large virulence plasmid 
found in all Shigella species.  These pathogenicity islands encode a number of 
virulence functions including antibiotic resistance, iron acquisition, proteases and 
cellular invasion (Schroeder and Hilbi, 2008).   
Potentially the most vital component of Shigella’s virulence arsenal is a large 
virulence plasmid that contains the genes required for cellular invasion.  These 
virulence plasmids range in size among species, but average in size at about 200 kb 
and they have been found to possess approximately 100 genes (Sansonetti 1985) 
(Yoshikawa 1988).  The virulence plasmid is primarily responsible for the uptake and 
dissemination of the bacteria throughout the cells of the colonic epithelium 
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(Wantanbe 1989).  The means for this uptake is via a type three secretion system 
(TTSS) which is encoded in a 31-kb “entry region” of the virulence plasmid.  Genes 
outside the “entry region” encode proteins for virulence factors that play roles after 
invasion of the host cell (Sansonetti 1985) (Yoshikawa 1988).  It has been determined 
that loss of this plasmid results in a loss in the ability to cause disease (Yoshikawa 
1986).  Additionally, transfer of the virulence plasmid into avirulent lab strains of E. 
coli confers an invasive phenotype to these non-pathogens (Formal 1982).    
Genes of the “entry region” fall into one of four categories based upon 
function.  The first category is comprised of proteins secreted by the TTSA.  These 
primarily consist of the ipa (invasion plasmid antigen) genes which are primarily 
effector and/or translocator proteins directly responsible for inducing cytoskeletal 
rearrangements, membrane ruffling and pathogen uptake.  Group two comprises 
genes that make up the type III secretion apparatus.  These consist of the mxi 
(membrane expression of ipa proteins) and the spa (surface presentation of ipa 
antigens) genes.  Many of these proteins are polymers that assemble to form the 
structural components of the TTSS apparatus including the basal body and the needle.  
The third category is reserved for the transcriptional activators of the TTSS genes in 
the “entry region,” such as mixE and virB.  Lastly, there are the molecular chaperones 
of the TTSS that help to maintain effector proteins while they are in the bacterial 
cytoplasm (Schroeder and Hilbi, 2008). 
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The Type III Secretion System 
 The TTSS is utilized by Shigella to invade the epithelial cells of the human 
colon.  It accomplishes this through an arsenal of proteins designed to penetrate and 
manipulate the targeted host cell.  Acting as a molecular syringe, the TTSA injects 
effector proteins into the host cell.  Once inside the cell, the effector proteins interact 
with the host cell’s signaling molecules to induce cytoskeletal rearrangements and 
promote uptake of the bacterium (Cornelis, 2006). 
 The basal body of the TTSA is a seven-ringed structure that spans the inner 
and outer membrane of the bacterium.  From the basal body extends the needle of the 
apparatus.  The needle protrudes from the outer membrane into the environment 
surrounding the bacterium.  Within the cytoplasm, at the bottom of the basal body, 
lies an ATPase implicated in protein unfolding, chaperone release and transmembrane 
transport of substrate proteins (Figure 1.1) (Blocker et al., 2001). 
 
The Ipas 
Effector proteins of the TTSS are utilized by Shigella to gain entry into and 
hijack the cytoskeletal proteins of the target cell to induce uptake of the bacterium.  
Beyond the polymer base of MxiH, IpaD sits at the tip of the needle apparatus.  Upon 
host cell contact or conditions that mimic host cell contact, additional effector 
proteins are secreted by the TTSA. In the lab, it has been demonstrated that the 
addition of the small amphipathic dyes Congo red, brilliant orange or Evans blue can 
induce secretion of TTSS effector proteins in the absence of host cell contact (Parsot  
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Figure 1.1 Schematic of the proteins of the type III secretion apparatus 
of Shigella flexneri. 
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et al., 1995) (Bahrani et al., 1997).  Additionally, serum has been demonstrated to 
have similar effects on the secretion system, though it is unclear how this latter 
mechanism works (Parsot et al., 1995) (Bahrani et al., 1997).  
 IpaD has been shown by Espina et al. to localize at the tip of the TTSA needle 
capping the MxiH polymers (Espina et al., 2006).  IpaD also possesses some form 
regulator function since ipaD null mutants are not able to invade and in overnight 
cultures they hypersecrete the TTSS effector proteins into the extracellular 
environment (Menard et al., 1994b) (Picking et al., 2005).  Work in progress by 
others in our group has demonstrated that the presence of bile salts (specifically 
deoxycholate) can induce IpaB to be secreted and sit at the tip of the needle after 
IpaD.  This has been proposed as a priming step, preparing the needle for host cell 
interaction via the cholesterol binding function of IpaB (Olive et al., 2007). 
 After IpaD, IpaB is recruited to the tip of the needle (Olive et al., 2007).  Prior 
to its secretion by S. flexneri, however, IpaB is bound by the molecular chaperone, 
IpgC, within the bacterial cytoplasm.  This association prevents IpaB degradation, 
aggregation and it is believed to maintain IpaB in a pre-secretion state for its 
subsequent passage through the TTSA needle (Menard et al., 1994a) (Page et al., 
1999).  Before S. flexneri is able to invade epithelial cells, it must escape from its host 
macrophage.  IpaB appears to be the protein responsible for inducing phagocyte 
apoptosis by inducing a caspase-1 dependent pathway (Zychlinsky 1998).  Like IpaD, 
IpaB appears to control effector regulation, since ipaB null mutants are also non-
invasive and hypersecrete effectors into overnight culture supernatant fractions 
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(Menard et al., 1994b).  Along with IpaC, IpaB is a component of the translocon, a 
pore like structure that is inserted into the host cell’s cytoplasmic membrane while 
maintaining contact with the TTSA needle component via IpaD.  This allows 
subsequent effector proteins to gain access to the cytoplasm of the target cell.   
 IpaB secretion is followed by the secretion of IpaC.  Prior to its secretion, 
IpaC also binds to IpgC in the bacterial cytoplasm, serving the same purpose as 
formation of the IpaB/IpgC complex (Menard et al., 1994a) (Page et al., 1999) .  In 
addition to forming the translocon, IpaC has been implicated in cell signaling within 
the host cell.  IpaC has been proposed to interact with a small Rho-family GTPase 
called Cdc42 leading to the formation of filopodial extensions (Tran Van Nheiu and 
Sansonetti, 1999). Although it has been shown that IpaC can nucleate actin, its 
interaction with Cdc42 remains largely unknown (Kueltzo et al., 2003).  IpaC 
induced membrane extensions gradually envelope the bacterium and lead to the 
formation of a phagosomal vacuole around the pathogen (Tran Van Nheiu et al., 
1999) 
Upon formation of the translocon, Shigella transfers additional TTSS effector 
proteins into the host cell to induce cytoskeletal rearrangement and phagocytosis 
(Menard et al., 1994b) (Watarai et al., 1995) (Menard et al., 1996) (Blocker et al., 
1999).  Though the exact pathway through which these interactions occur have yet to 
be elucidated.  IpaA, IpaB1, IpaB2, IpaC and IpgD are the most studied of these 
effector proteins responsible for inducing phagocytosis by the host eukaryotic cell.  
IpaA possess the ability to depolymerize actin, while IpaB1 and IpaB2, appear to 
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mimic RhoG and RhoA, respectively, inducing the formation of lamellipodia and 
actin stress fibers (Alto et al., 2006) (Handa et al., 2007)   Finally, IpgD has been 
described as a phosphoinositide 4-phosphatase, which facilitates the hydrolysis of 
phosphatidylinositol-4,5-biphosphate [PtdIns(4,5)P2], resulting in the dissociation of 
the cytoskeleton from the plasma membrane (Hilbi, 2006) (Niebuhr et al., 2002).    
 
Escape into the cell cytoplasm 
 In order to replicate and spread throughout the colonic epithelium, Shigella 
must escape the phagosome and gain access to the cytoplasm of the host cell.  
Proteins required for phagosomal escape appear to be independent of those required 
for bacterial uptake.  In S. flexneri strains in which the 31-kb entry region is deleted, 
and complemented with the Salmonella enterica serovar Typhimurum Salmonella 
pathogenicity island -1 (SPI-1), invasiveness and phagosomal escape are restored 
(Paetzold et al., 2007).  These results would be expected as many of the genes in SPI-
1 are homologous to those found on the S. flexneri virulence plasmid.  Unlike, S. 
flexneri, S. typhimurium does not require escape from the phagosome to replicate 
(Takeuchi, 1967) (Sansonetti et al, 1986).  In S. flexneri strains lacking the entire 
virulence plasmid, but containing SPI-1 are capable of invasion, but cannot escape the 
phagosome, suggesting genes vital to S. flexneri phagosomal escape lie outside of the 
31-kb entry region of the virulence plasmid (Paetzold et al., 2007).      
 Once Shigella has escaped the phagosome, it can spread laterally across the 
colonic epithelium.  Though Shigella is non-motile, it possesses the ability to move 
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through the host cell cytoplasm via actin-based motility.  IcsA (intracelluar spread) 
localizes at one pole of the bacterium and mediates actin polymerization.  Through 
the aid of IcsP and PhoN2, IcsA interacts with host cell N-WASP and Arp2/Arp3, to 
nucleate actin and move the bacterium through the cytoplasm.  At the opposite pole 
of the bacterium, VirA works to depolymerize α-tubulin to create a path for Shigella 
to move through (Schroeder and Hilbi, 2008).   
 Eventually, the bacterium makes its way to the tight junctions between the 
host epithelial cells.  Here it enters the neighboring cell to reside in a double-
membraned vacuole.   This vacuole is lysed and the pathogen escapes into the 
cytoplasm of the neighboring cell.  The bacterium will then replicate and continue to 
spread laterally across the epithelium (Parsot, 1994). 
 Research foci 
The research presented here addresses the interactions of IpaB and IpaC with 
one another and with the chaperone IpgC.  Most research in the field has focused on 
characterizing these proteins individually rather than in conjunction with their partner 
proteins.  Structure function analyses of both IpaB and IpaC have helped to identify 
key regions and their associated functions.  Data here extend and complement these 
structure-function analyses and more intimately characterize key regions within IpaC.   
Because these proteins spend their functional lives in complexes with either a 
chaperone or within the translocon, it is also important to investigate the influence 
that these complexes have on protein structure and function.  IpaBC translocon 
formation is vital to Shigella invasion.  In the absence of the translocon, the pathogen 
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is no longer invasive and unable to elicit disease in the host.  Though it is widely 
accepted that IpaB and IpaC form a pore that inserts into the host cell membrane, 
characterization of this complex has been relatively neglected.  Using various 
biophysical and molecular methods, we have characterized some of the structural 
aspects of the IpaBC pore and how these proteins work to interact with artificial 
membranes (Chapter 4).    
In addition, little research has been devoted to characterizing the influence of 
IpgC binding upon the solution properties of IpaB or IpaC.  Recently, we utilized 
tryptophan scanning mutagenesis to determine the polarity of specific 
microenvironments within IpaC and how those environments are influenced by IpgC 
binding.  Chapter 3 addresses the IpaC/IpgC interaction.  Results from this study have 
suggested that IpgC binding has a strong influence on key regions of the N- and C-
termini of IpaC (Birket et al., 2007).  Here, we have begun to use the same techniques 
to identify and characterize residues within IpaB influenced by IpgC binding (Chapter 
5). 
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CHAPTER 2 
Materials and Methods 
 
Reagents and Buffers 
 
10 X Buffer Z 
2.42 g Tris 
2.92 g NaCl2 
100 ml diH2O 
 
20 mM Citrate Phosphate Buffer,  pH 7 
Solution 1(0.4 M Sodium phosphate dibasic) 
56.78 g Na2HPO2, anhydrous 
1.00 L diH2O 
Solution 2 (0.4 M Citric Acid) 
76.85 g C6H8O7, anhydrous 
1.00 L diH2O 
 
(90 ml Solution 1) + (10 ml of Solution 2) + (1900 ml diH2O) 
 
Coomassie Blue Protein Gel Stain 
250 ml methanol 
1.25 g Coomassie brilliant blue 
75 ml acetic acid 
175 ml diH2O 
 
Congo Red Agar (CR) 
40.0 g TSA 
4.00 g agar 
0.300 g Congo Red 
1.00 L diH2O 
 
DNA Electrophoresis 10% Agarose Gel 
50 ml 1X TAE 
30 µL ethidium bromide 
 
DNA Electrophoresis Loading Buffer 
125 mg Bromophenol blue 
125 mg xylene cyanol FF 
20 g sucrose 
 
 
8X His-Tag Binding Buffer 
2.72 g imidazole 
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237 g NaCl 
19.36 g Tris 
Adjust to 1.00 L with diH2O 
pH to 7.9 
 
4X His-Tag Charge Buffer 
52.56 g NiSO4 
Adjust to 500 ml with diH2O 
 
4X His-Tag Elution Buffer 
136 g imidazole 
58.44 g NaCl 
4.84 g Tris 
Adjust to 500 ml with diH2O 
pH to 7.9 
 
4X His-Tag Strip Buffer 
74.4 g EDTA 
58.44 g NaCl 
4.84 g Tris 
Adjust volume to 500 ml with diH2O 
pH to 7.9 
 
8X His-Tag Wash Buffer 
5.44 g imidazole 
117 g NaCl 
9.68 g Tris 
Adjust volume to 500 ml with diH2O 
pH to 7.9 
 
Luria-Bertani Broth (LB) 
20.0 g LB broth 
1.00 L diH2O 
 
Luria-Bertani Agar (LB) 
40.0 g LB agar 
1.00 L diH2O 
 
MEM-Glucose 
9.30 g MEM 
2.20 g NaHCO3 
4.50 g glucose 
1.00 L diH2O 
Filter sterilize 
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MEM-Gentamycin 
9.30 g MEM 
2.20 g NaHCO3 
50.0 ml calf serum 
50.0 g gentamycin 
1.00 L diH2O 
Filter sterilize 
 
 
 
10X Phosphate Buffered Saline (PBS) 
85.0 g NaCl 
10.7 g sodium phosphate, dibasic 
3.90 g sodium phosphate, monobasic 
1.00 L diH2O 
 
3X SDS Sample Buffer 
2.00 g SDS 
10.0 ml glycerol 
0.10 g bromophenol blue 
5.00 ml 2- mercaptoethanol 
50.0 ml diH2O 
 
10% SDS-PAGE Separating Gel 
4.00 ml diH2O 
2.50 ml 1.5 M Tris-HCl, pH 8.8 
100 µl 10% SDS 
3.33 ml 30% Bis:Acrylamide  
 
12% SDS-PAGE Separating Gel 
3.00 ml diH2O 
2.50 ml 1.5 M Tris-HCl, pH 8.8 
100 µl 10% SDS 
4.00 ml 30% Bis:Acrylamide  
 
15% SDS-PAGE Separating Gel 
2.50 ml diH2O 
2.50 ml 1.5 M Tris-HCl, pH 8.8 
100 µl 10% SDS 
5.00 ml 30% Bis:Acrylamide  
 
5% SDS-PAGE Stacking Gel (2) 
2.85 ml diH2O 
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1.25 ml 0.5 M Tris-HCl, pH 6.8 
50.0 µl 10% SDS 
1.00 ml 30% Bis:Acrylamide 
 
SDS-Page Running Buffer 
2.42 g Tris 
14.41 g glycine 
10.0 ml SDS 
1.00 L diH2O 
 
50X TAE (DNA Gel Running Buffer) 
242 g Tris 
57.1 ml acetic acid 
100 ml .5 M EDTA 
Adjust to 1.00 L with diH2O 
 
10X Tris Buffered Saline (TBS) 
12 g Tris 
87.7 g NaCl 
Adjust to 1.00 L with diH2O 
pH with HCl to 7.0 
 
Tryptic Soy Broth (TSB) 
25.0 g TSB broth 
1.00 L diH2O 
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IpaB tryptophan mutant construction 
All tryptophan mutations in ipaB were generated using inverse PCR with 
pHS2-IpaB, encoding IpaB, as the template.  Primers were made to encode 
GAGAGA, a restriction site flanking the codon to be mutated and approximately 18 
nucleotides beyond the mutation site.   Primers are listed in Table 2.1.  Inverse PCR 
produced a linear fragment, which was subsequently digested with the appropriate 
restriction endonucleases and intramolecularly ligated.  GAGAGA sequences are 
present at the ends of the fragment to increase the efficiency of restriction digestion.  
Ligation products were transformed into Nova Blue E. coli.  Resulting plasmids were 
purified using the QIAGEN QIAquick™ plasmid purification kit.  Purified plasmids 
were electroporated into the ipaB null Shigella flexneri strain SF620 and placed onto 
TSA plates containing Congo red and ampicillin.  Ampicillin resistant, red colonies 
were chosen for further assays as these contained both the electroporated plasmid and 
the virulence plasmid based on Congo red selection.  W105F was constructed to 
remove the natural tryptophan residue in IpaB and this was used as a template for 
subsequent mutants in which a Trp was introduced at novel sites.    
 
Construction/Production of Recombinant Proteins 
Mutated ipaB genes were subcloned from pHS2 into pACYC-Duet 1 via 
flanking NdeI and KpnI sites.  The resulting mutant IpaB/pACYC-Duet 1 constructs 
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Mutant Primer 
Names 
Sequence (3’-5’) 
B50f GAGAGAGAGATTTAAATCCCAGCAACAGGCAAG  
W105F 
B51r GAGAGAGAGATTTAAATGCAGTAATTTTATTTGTTAATG 
B53f GAGAGAGAGACGCGTGACTATGAAAAACAAATTAATAA  
L133Wa 
B54r GAGAGAGAGACGCGTCCATCCTTCAGTTTCAGATAGAA 
B57f GAGAGAGAGGCCGCTTGGTCTGGAGGAGCCTCTCTA  
F328Wa 
B58r GAGAGAGAGGCGGCCGCAACAACACTAACGATAGT 
B59f  GAGAGAGAGGCCGGCGCTCTTGTCCTAGTT  
I402Wa 
B60r GAGAGAGAGGCCGGCGATTGCCCCCAGCCAAGAGCCAATCTATTTGGCTT 
B61f GAGAGAGAGCTGCAGCAAACTACTGCTTGAGGC  
I574Wa 
B62r GAGAGAGAGCTGCAGCCATGCTTTGCAACATCAGTT 
 
Table 2.1 Table of primers for IpaB tryptophan scanning mutants 
aMutations after 105 are double mutants containing W105F and the indicated mutation. 
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were then transformed into Nova Blue E. coli.  Transformants were screened with 
Duet UP2 and T7 terminator primers.  Positive plasmids were then purified using a 
QIAGEN QIAquick™ plasmid purification kit and then co-transformed with 
IpgC/pET15b into Tuner (DE3) E. coli.  To select for bacteria containing both 
plasmids, transformations were plated on LB plates containing ampicillin and 
chloramphenicol.  Each plate was resuspended in 5 ml of LB and divided evenly 
between 2 L of LB, each containing 100 µg/ml ampicillin and 25µg/ml 
chloramphenicol.  Cultures were grown to mid-log phase (OD600 = 0.5) when protein 
expression was induced using 0.5 M IPTG.  Induced cultures were grown for an 
additional three hours.  Bacteria were then collected by centrifugation and 
resuspended in 40 ml/L of culture, with 1X His-tag binding buffer.  The bacterial 
suspension was frozen at - 20°C.  
 
SopE2 and Cdc42 Protein Purification 
Recombinant GST-Cdc42 and GST-SopE2 were purified after being 
synthesized in E. coli BL21 (DE3).  Both proteins were designed with GST fusion 
tags to aid in purification.  Protein expression was induced by adding 0.5 M IPTG to 
mid-log phase bacterial cultures.  After three hours, the cells were harvested by 
centrifugation and resuspended in 40 ml 1X PBS and then frozen at -20oC overnight.  
The suspension was thawed and sonicated to complete bacterial lysis and shear 
bacterial DNA.  The insoluble material was removed by centrifugation at 12,000 x g 
for 12 minutes.  The GST fusion proteins remained in the supernatant fraction.  
 22 
Chromatography using immobilized glutathione was used to affinity purify the GST 
fusion proteins.  For both proteins, a bed volume of 10 µl per ml of supernatant was 
poured for each column used.  Elution was accomplished using 10 mM glutathione in 
1X TBS.  Proteins were dialyzed against 1X TBS to remove the glutathione from the 
solution.  The GST protein tag was cleaved from the protein with thrombin and the 
released tag was removed by adsorption onto immobilized glutathione resin.  The 
protein samples were stored at -80°C.  
 
IpaB/IpgC and IpaC/IpgC Protein Purification 
Tuner (DE3) cells containing pACYC-IpaB/pET15b-IpgC or pACYC-
IpaC/pET15b-IpgC were grown in LB containing 100 µg/ml ampicillin and 25 µg/ml 
chloramphenicol.  At mid-log phase protein expression was induced by the addition 
of 0.5M IPTG.  Induced cultures were grown for three hours and then centrifuged at 
4900 x g for eight minutes.  Cell pellets were resuspended in 40 ml/L of culture with 
1X His-tag binding buffer.  Bacterial suspensions were frozen at -20°C.   
 
Affinity Protein Purification of His-Tag Containing Proteins 
Frozen bacterial suspensions were thawed, sonicated and clarified by 
centrifugation for 10 minutes at 10000 x g.  Five ml of iminodiacetic acid Sepharose 
were washed with five column volumes (CV) of distilled water.  The resin was 
charged with three CV of 1X His-tag charge buffer and then five CV of 1X His-tag 
binding buffer.  Clarified supernatants were applied to the column, which was washed 
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with an additional five CV of binding buffer.  Non-specifically bound proteins were 
removed with five CV of 1X His-tag wash buffer and bound proteins were then eluted 
in three CV of 1X His-tag elution buffer.  Fractions were collected and analyzed by 
SDS-PAGE gel to check for protein.  The resin was stripped with three CV of 1X 
His-tag strip buffer and stored at 4 °C.   
 
FPLC Purification of IpaB/IpgC and IpaC/IpgC 
Fractions from affinity chromotography containing IpaB/IpgC or IpaC/IpgC 
were pooled.  EDTA and DTT were added to a final volume of 1 mM and 2 mM 
respectively.  Samples were loaded onto a HiLoad 26/60 Superdex 200 preparative 
grade column equilibrated with 10 mM Tris-HCl pH 7.2, 150 mM NaCl, 0.5 mM 
DTT.  Fractions again were analyzed by SDS-PAGE.  Those fractions containing the 
complexes were pooled and dialyzed into sodium citrate phosphate buffer, pH 7.  
Proteins were stored at -80°C. 
 
Separation of IpaB From IpgC 
IpaB/IpgC was incubated at 4°C with 2% n-octyl-poly-oxyethylene (OPOE) 
for at least 1 hour.  IpaB was separated from the chaperone using a five ml HiTrap™ 
Chelating HP column.  The column was prepared according to manufacturer’s 
directions.  The column was washed with three CV of filtered distilled H2O followed 
by 0.5 CV of filtered 1X charge buffer.  An additional three CV of deionized water 
were applied to the column.  To bind His-tagged IpgC, five CV of 1X binding buffer 
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with 1% OPOE was applied to the column.  The IpaB/IpgC in 2% OPOE was then 
applied to the column and flow through fractions were collected.  Sample was 
followed by five CV of binding buffer with 1% OPOE and then IpgC was eluted in 
three CV of 1X elution buffer.  All fractions were checked for IpaB and IpgC through 
SDS-PAGE.  IpaB eluted in the flow through and binding buffer fractions, while free 
IpgC eluted in the elution buffer.   
 
IpaB/IpaC Complex Purification 
The IpaB/IpaC pore complex was purified from an ipaA/ipgD null mutant 
Shigella flexneri.  Bacteria were grown to OD600 of 1.0 in 1 L TSB with 50 µg/L of 
kanamycin in a shaking incubator.  Bacteria were harvested by centrifugation in a 
swinging bucket rotor at 4900 x g for 12 minutes.  Supernatants were discarded.  To 
induce secretion of effector proteins, pellets were resuspended in ice cold 10 mM 
sodium phosphate, 150 mM sodium chloride and harvested a second time for 12 
minutes.  Bacteria were resuspended in 860 mM Congo red in 10 mM sodium 
phosphate, 150 mM NaCl at 37 °C.  Secretion was induced by shaking the Congo red 
mixture at 37 °C at 200 rpm for 15 minutes.  After incubation, bacteria were removed 
by centrifugation at 9000 x g for 20 minutes and supernatants were dialyzed against 
20 mM Tris pH 7.4.  Dialyzed Congo red supernatant was applied to a 5ml HiTrap™ 
Q sepharose FF column to remove the Congo red dye.  Proteins were eluted in 20 
mM Tris 1M NaCl.  Fractions containing IpaB, IpaC, and IpaD were applied to a 
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HiLoad 26/60 Superdex 200 preparative grade column equilibrated with 1X TBS .5 
mM DTT to separate the IpaB/IpaC pore from IpaD by size exclusion. 
 
Measurement of Protein-Protein Interaction by Fluorescence Polarization  
A Beacon Fluorescence Polarimeter was used to measure binding events 
between IpaC or SopE2 and FITC labeled Cdc42.  In a 12 x 75 mm test tube FITC 
labeled Cdc42 was added to buffer to a concentration of 0.5 µM.  20 µM EDTA was 
added to chelate magnesium and finally 20 µM of GTP was added to the reaction.  
The reaction was then thoroughly mixed and then 5 mM magnesium was added to 
saturate any remaining EDTA.  IpaC or SopE2 were added the reaction was allowed 
to incubate at 22 ºC for 30 minutes.  Emission spectra were read using a Beacon 
Fluorescence Polarimeter.  IpaC or SopE2 were added to the solution in increasing 
amounts and polarization was measured over time. 
 
Gentamycin Protection Invasion Assay 
Henle 407 cells were seeded on a 24 well tissue culture plate and incubated in 
CO2 at 37 °C until semi-confluent.  Shigella strains were grown at 37 °C with shaking 
in 10 ml of TSB to mid-log phase (OD600 = 0.5).  One µl of the bacterial culture was 
added to Henle cells in MEM-glucose and centrifuged at 800 x g for five minutes to 
force contact.  Plates were incubated for 30 minutes at 37 °C in a CO2 incubator.  
Cells were then washed with MEM-gentamycin (50 grams/L) and incubated 37 °C in 
a CO2 incubator for one hour in MEM-gentamycin to kill any extracellular Shigella.  
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After incubation, the MEM-gentamycin was removed by aspiration, cells were 
washed three times with MEM-glucose, lysed with melted agarose in deionized water 
and then overlaid with melted 2X LB in agar.  Once the agar solidified, cells were 
incubated at 37°C overnight.  Colonies were counted and invasion was calculated 
relative to complimented Shigella strains.  
 
Contact Mediated Hemolysis 
Shigella strains were grown to mid-log phase at 37 °C with shaking in 10 ml 
of TSB.  Bacteria were collected by centrifugation at 3200 x g.  Bacteria were 
resuspended in 200 µl of 1X PBS.  Sheep erythrocytes were washed at room 
temperature with 1X PBS and resuspended in 1X PBS to the original cell 
concentration.  Fifty µl of red blood cells (RBCs) were aliquoted into a 96 well 
microtiter plate to which 50 µl of the bacterial cell suspension was added per well.  
Contact was induced by centrifugation at 2500 x g at 22 °C for 10 minutes.  
Microtiter plates were then incubated at 37°C for 1 hour.  After incubation, 
RBC/bacterial pellets were vigorously resuspended in ice cold 1X PBS and 
centrifuged at 2500 x g for 15 minutes at 4°C.  Supernatants were transferred to clean 
empty wells.  Hemoglobin release was measured by monitoring absorbance at 545 nm 
on a µQuant™ microtiter plate reader. 
TCA Precipitation of Secreted Proteins 
Shigella strains were grown in 10 ml of TSB overnight in a shaking incubator 
at 37°C.  Overnight cultures were centrifuged at 4000 rpm for 10 minutes at 4°C.  
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Supernatants were transferred to glass Corex tubes.  Pellets were resuspended in 200 
µl of deionized water, 150 µl 3X sample buffer and 10 µl 1.5 M DTT.  Pellets were 
then frozen at -20°C for future use.  1.1 ml of ice cold 100% trichloroacetic acid 
(TCA) was added to supernatants and after 30 minutes, the sample centrifuged at 
9000 x g for 12 minutes.  Supernatants were discarded and remaining pellets were 
washed with 10 ml of ice cold 5% TCA and centrifuged.  Supernatants were 
discarded and pellets were washed twice in 10 ml of ice cold acetone.  After the 
acetone washes, Corex tubes were inverted to dry pellets.  Final samples were 
resuspended in 400 µl of cold 1X PBS, 200 µl 3X sample buffer and 15 µl 1.5 M 
DTT.  Samples were then seperated on a 15% resolving SDS-PAGE gel. 
 
Western blot 
To analyze the presence of proteins in bacteria and supernatant samples from 
trichloroacetic acid precipitations were run on a 15% resolving SDS-PAGE gels and 
the gels were incubated in 1X blotting buffer for 20 minutes.  Seperated proteins were 
blotted onto nitrocellulose using a BioRad Transblot-SD Semidry Transfer Cell for 35 
minutes at 15V at constant voltage.  After blotting, the nitrocellulose membrane was 
incubated in 1X blocking buffer for 45 minutes and in primary antibody diluted 
1:1000 at 4 °C overnight.  Nitrocellulose membranes were washed in 1X PBS-Tween 
20 three times for five minutes each.  Membranes were incubated with secondary 
antibody diluted 1:10,000 for 1 hour at room temperature.  Membranes were then 
washed an additional three times with 1X PBS-Tween 20 and finally, twice with 1X 
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PBS for five minutes with shaking.  Membranes were then scanned on a Li-Cor 
Odyssey™ Infrared scanner and imaged using the Odyssey Software. 
 
Circular Dichroism Spectroscopy of Purified Proteins and Protein Complexes 
Far UV CD spectra and thermal unfolding monitoring at 222 nm were 
performed using a Jasco J720 spectropolarimeter. Far UV spectra were collected at a 
wavelength range of 190 to 260 nm at a scan rate of 20 nm/min.   A 0.1 cm path 
length cell quartz cuvette was employed and spectra were acquired in triplicate and 
averaged. The thermal-induced unfolding transitions were acquired using a 0.1 cm 
path length cell quartz cuvette with a temperature ramping rate of 15°C per hour. 
Protein concentrations ranged from 1 to 10 µM with all experiments performed in 
phosphate citrate buffer (pH 7) to minimize pH shifts induced by temperature. CD 
signals were converted to molar ellipticities to normalize for differences in protein 
concentration and the unfolding transitions were analyzed using the Jasco Spectral 
ManagerTM and Sigma Plot softwares. 
 
Preparation of Phospholipid Vesicles 
Aliquots of DOPC, DOPG, and cholesterol in chloroform were dried under 
helium and vacuum for 3 hours to create lipid films.  DOPC:DOPG (w/w) and 
DOPC:DOPG:cholesterol (w/w/w) concentrations varied based on desired lipid 
composition. Lipid films were rehydrated in 100 mM sulforhodamine B (SRB) in 
water by incubating at room temperature for 10 minutes and then resuspended by 
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using a pipette.  Rehydrated films were sonicated for 15 seconds and extruded 
through a 100-nm pore size membrane 10 times at 45oC.  To remove untrapped dye, 
extruded SRB containing liposomes were loaded onto a Sephadex G-50 gel filtration 
column equilibrated with 1X PBS or 1X TBS.  Peak fractions were selected visually.  
Fractions were stored at 4oC and used within one week. 
 
Monitoring Rhodamine Release From Phospholipid Vesicles 
SRB release from phospholipid vesicles was monitored using a SPEX 
FluoroMax™ spectrofluorometer. Baseline fluorescence was measured for 30 
seconds.  Protein was added and SRB release was detected as an increase in 
fluorescence intensity over time for 250 seconds.  Triton X-100 (0.1%) was added to 
completely disrupt liposomes as a control for complete SRB release.  IpaD was used 
as a negative control for liposome disruption. 
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CHAPTER 3 
Potential IpaC protein interactions with IpgC 
 
Introduction 
Bacterial Secretion Systems 
Many gram negative pathogens utilize secretion systems to deliver virulence 
factors to targeted host cells.  To date, six distinct bacterial secretion systems have 
been identified in bacteria.  Type II and type V secretion systems are Sec-dependent, 
requiring the general secretory pathway (Sec components) for protein translocation 
across the inner membrane.  The Sec pathway catalyzes and translocates proteins 
across the bacterial inner membrane to the periplasmic space.  Type I, type III, type 
IV secretion systems are Sec-independent (Harper and Silhavy, 2001).  A sixth 
secretion system has recently been described in Vibrio cholerae, Pseudomonas 
aeruginosa, and Burkholderia cneocepaciae, but to date, very little is known about 
this system.  
Type I secretion systems contain an ATP-binding cassette (ABC), a 
membrane fusion protein and an outer membrane component.  Type I secretion 
allows secretion across the inner and outer membranes in a single step (Fath and 
Kolter, 1993).  Type II secretion pathways are composed of 12-14 protein 
components that interact with the Sec-pathway.  Proteins targeted for transport 
through the type II secretion system are exported from the cytoplasm to the periplasm 
via Sec-machinery.  The type II secretion system then transports the protein from the 
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periplasm to the extracellular environment (Russel, 1998).  Type III secretion systems 
are composed of 25 or more protein components and allow direct, ATPase driven 
transport of virulence factors from the bacterial cytoplasm to the cytoplasm of 
targeted host eukaryotic cells.  Protein transport in type III secretion is Sec-
independent and is also referred to as contact dependent secretion (Hueck, 1998).  
Type IV secretion systems were first identified as conjugal transfer systems that 
transferred bacterial DNA into targeted bacterial hosts.  These pilus-like transport 
systems have now been implicated in exporting multisubunit and monomeric proteins 
(sometimes directly into eukaryotic target cells) in addition to DNA (Winans, et al., 
1996).  Type V secretion systems are autotransporter systems that work in 
conjunction with Sec proteins.  Proteins exported by the type V secretion system are 
large multidomain proteins consisting of five regions; a Sec-dependent signal domain, 
the mature portion of the protein, and the α-, β- and γ-regions.  The Sec machinery 
uses the Sec signal to move the protein from the cytoplasm to the periplasm.  The β-
region then inserts and forms a pore in the outer membrane.  The remaining regions 
of the protein pass through this pore, are cleaved by autoproteolysis and released to 
the extracellular environment.  They are further processed through subsequent 
autoproteolysis events (Klauser et al., 1993).  Type VI secretion systems have been 
identified in several gram negative organisms, but the structure and mechanism of 
this secretion system has yet to be characterized (Aubert  et al., 2008) (Zheng and 
Leung, 2007) (Pukatzki et al., 2006).  
 32 
S. flexneri utilize type III secretion to promote pathogen uptake in targeted 
epithelial cells of the large intestine (Sansonetti et al., 1982).  Upon host cell contact 
or conditions that mimic host cell contact, the S. flexneri type III secretion system 
(TTSS) exports effector proteins through the external needle apparatus and to the 
membrane and cytoplasm of targeted host cells.  “Early” effector proteins, IpaB and 
IpaC, bind to one another following their export and form the “translocon” within the 
host cell membrane.  The IpaB/IpaC translocon inserts into host cell membranes and 
forms a pore through which subsequent effector proteins can pass into the targeted 
host cell’s cytoplasm for promoting bacterial invasion (Davis et al., 1998) (Blocker et 
al., 1999).  In the absence of the translocon, entry into targeted cells cannot proceed 
(Menard et al., 1993).  Prior to receiving the signal for secretion, IpaB and IpaC are 
partitioned to the bacterial cytoplasm where they bind independently to IpgC, waiting 
in queue until they are secreted by the type III secretion apparatus (TTSA) (Menard et 
al., 1994, Page et al., 1999). 
 
The Molecular Chaperone IpgC 
Invasion plasmid gene C (IpgC) is the molecular chaperone for the 
translocator proteins IpaB and IpaC in S. flexneri.  Chaperones of type III secretion 
systems fall into three classes.  Class I chaperones are those associated with late 
effector proteins.  Class I can be further divided into class IA and IB based on their 
association with one or multiple effector proteins, respectively.  Class II chaperones 
bind to known or proposed translocator proteins, while class III chaperones are 
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associated with proteins within the flagellar system (Cornelis and Gijsegem, 2000, 
Page et al., 2001).    
IpgC is a class II chaperone of the S. flexneri type III secretion system (Page 
et al., 2001).  Like all other chaperones from type III secretion systems, IpgC is small 
(17 kDa), possesses a highly acidic pI (4.6) and serves multiple roles as a part of the 
TTSS.  As previously mentioned IpgC binds separately to IpaB and IpaC.   These 
associations serve several purposes.  As mentioned in the introduction, one function is 
to prevent IpaB and IpaC from associating with each other while still in the bacterial 
cytoplasm.  This prevents aggregation of the early effector/translocator proteins 
within the bacterial cytoplasm and premature formation of the translocon pore 
(Menard et al., 1994a).  Additionally, IpgC has been proposed to hold both IpaB and 
IpaC in a secretion competent state.  Due to the large sizes of the translocator 
proteins, it is evident that secretion of each IpaB and IpaC would have to occur with 
the protein in some form of elongated state in order to accommodate the small inner 
diameter (~2.5 nm) of the needle apparatus (Blocker et al., 1999).  It has been shown 
here and elsewhere that in the absence of IpgC, IpaB and IpaC can insert into and 
disrupt liposomes (DeGeyter et al., 1997).  However, when IpgC is bound to the 
effector proteins, this liposome destabilizing activity is blocked (Birket et al., 2007).  
When IpgC is absent in the bacterium, IpaB and IpaC are thus degraded to similarly 
protect the bacterial cytoplasmic membrane (Menard et al., 1994).       
In addition to its chaperone function, IpgC has been shown to serve as a 
transcriptional co-activator of virA and ipaH9.8 (Munson et al., 2008).  It has been 
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demonstrated that IpgC can be co-purified with MxiE, suggesting that it works in 
conjunction with MxiE to increase both the expression of VirA and IpaH9.8 (Munson 
et al., 2008).  Initially, this association was thought to be transient but it is now 
proposed to only be possible upon release of IpaB and IpaC from IpgC, indicating the 
increase in transcription of the above proteins is signaled only after the translocon has 
been formed and IpgC released from its translocator protein partner (Munson et al., 
2008).   
Because IpaC and IpaB possess little or no sequence homology with each 
other, the manner and ability of IpgC to bind both proteins is of great interest.  IpaC is 
a 42-kDa protein consisting of several key functional and structural regions (Figure 
3.1).  Within these regions are a transmembrane domain, a putative coiled-coil region 
and a TTSS secretion signal.  IpaC has multiple functions as a Shigella virulence 
determinant.  It has been demonstrated to disrupt liposomes, promote invasion of 
epithelial cells, and interact with actin and small signaling molecules (Picking et al., 
2001) (Kueltzo et al., 2003).  Additionally, the 19 C-terminal amino acids of IpaC are 
proposed to make up a distinct effector region of the protein.  Here we investigate the 
influence of IpgC binding on IpaC structure and function and the importance of 
IpaC’s C-terminal tail in IpaC invasion function (Picking et al., 2001) 
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Figure 3.1  Schematic diagram of regions of IpaC.  Residues 1-20 encode a 
TTSS.  Residues 50-80 are required for binding and interactions with IpgC and 
IpaB.  Amino acids 100-120 and 150-170 are transmembrane domains while 120-
150 form a loop between to the two transmembrane domains.  Residues 300-344 
are a putative trimeric coiled-coil and the penultimate 19 amino acids of IpaC are 
involved in effector function. 
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Results 
IpaC/IpgC Protein Purification 
Purification of IpaC/IpgC complexes is achieved through co-expression of both IpaC 
and His-tagged IpgC in Tuner (DE3) E. coli.  This association inside S. flexneri 
maintains IpaB and IpaC as part of a soluble complex, prevents IpaB association with 
IpaC and prevents IpaC from being targeted for degradation in the bacterial 
cytoplasm as part of a premature translocon complex (Birket et al., 2007).  Large 
quantities of recombinant IpaC/IpgC complex can be prepared by affinity 
chromatography.  After initial complexes made in E. coli are prepared by Ni+ affinity 
chromatography, they can then be separated from free IpgC by size exclusion 
chromatography (Figure 3.2).  It has been demonstrated that the effector/chaperone 
complex PopD/PcrH, of the type III secretion system of P. aeruginosa, can be 
separated into its component proteins by decreasing the pH of the buffer.  Because of 
similarities between the S. flexneri IpaC/IpgC complex and the P. aeruginosa 
effector/chaperone complex, the same method of decreasing the protein’s 
environmental pH to release the chaperone was employed (Schoehn et al., 2003).  
Upon lowering the pH to 5.0 the translocator/chaperone complex was partially 
separated into its component proteins and these were further separated by a second 
size exclusion chromatography step (Figure 3.2).  This provides a convenient method 
for purifying IpaC in the absence of chaotropic agents such as urea, which has always 
been a difficulty in the study of this protein. 
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Figure 3.2 Purification of IpaC/IpgC complex and purified IpaC. 
I.  IpaC/IpgC complexes were coexpressed in E. coli and were purified by affinity 
chromatography.  Peak fractions were determined by SDS-PAGE. 
II.  IpaC was separated from IpgC by lowering the solution pH to 5 and purified by 
Superdex 16/60 size exclusion column chromatography.  IpaC freed from the 
IpaC/IpgC complex is labeled.  Free IpgC elutes later at a lower molecular weight 
(not shown).  Peak fractions were analyzed using SDS-PAGE. 
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Circular Dichrosim Spectroscopy of the IpaC/IpgC complex 
Circular dichroism (CD) spectroscopy is a useful tool for determining changes 
in the global secondary structure of proteins.  CD spectroscopy uses circularly 
polarized light to measure the differences in the adsorption between left and right 
handed polarized light.  Because chiral molecules, such as the α-carbon of the peptide 
backbone, exhibit measurable differences in CD, we can use these measurements to 
provide an estimate of the global secondary structure content of proteins within a 
sample.  Secondary structure components produce characteristic UV spectra with 
characteristic peaks and valleys at specific wavelengths (Bloemendal and Jiskoot, 
2005).    Far UV spectra of IpaC, IpgC and IpaC/IpgC complexes as monitored by CD 
reveal that IpgC does significantly influence IpaC structure (Figure 3.3).  In order to 
quantify secondary changes far UV spectra were analyzed using the freeware 
Dichroweb.  Dichroweb uses a wide range of databases to compare experimental data 
to known protein structures and spectra (Lobley et al., 2002).  Dichroweb analysis 
confirms that upon IpgC binding α-helical structure of IpaC increases from 30% to 
53%, while the β-sheet content decreases significantly from 22% to 8% (Table 3.1).  
This suggests that upon IpgC binding IpaC undergoes a significant conformational 
change, resulting in a loss of β-structure compensated by an increase in α-helicity 
(Birket et al., 2007).   
Thermal unfolding as monitored by CD supports these findings.  Thermal 
unfolding or melting temperatures of proteins can be determined by monitoring α-
helical proteins at 222 nm over increasing temperatures.  As the temperature  
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Figure 3.3  Far UV CD spectra and thermal melting temperatures of purified 
IpaC, IpgC and IpaC/IpgC complexes. 
Far UV spectra of purified proteins and protein complexes using circular dichroism 
was measured at a wavelength range of 190 to 280 nm.  Spectra are an average of at 
least two representative spectra. (Birket et al. 2007) 
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Protein  α-helix β-sheet Turns Random 
IpaC 0.30 0.23 0.18 0.31 
IpgC 0.52 0.21 0.11 0.17 
IpaC/IpgCa 0.42 0.22 0.14 0.24 
IpaC/IpgCb 0.53 0.08 0.12 0.28 
 
Table 3.1 Deconvolution of the far-UV CD spectra for purified IpaC, IpgC 
and IpaC/IpgC complexes. 
Deconvolution of the far-UV spectra as analyzed by Dichroweb using SELCOM 
and CONTIN algorithms.  a Calculated or theoretical sums of secondary structure 
elements.  b Experimentally derived values for the binary complex as determined 
by far-UV CD spectroscopy (Birket et al., 2007). 
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Protein  Melting Temperature (Tm) ± SE, °C 
IpaC 45.5 ± 0.3 
IpgC 53.9 ± 0.2 
IpaC/IpgC 56.3 ± 0.1 
 
 
Table 3.2  Thermal melting temperatures of purified IpaC, IpgC and 
IpaC/IpgC complexes. 
Thermal melting temperatures were monitored at 222 nm to probe changes 
in α-helical content over increasing temperature (Birket et al., 2007). 
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increases, proteins depart from their normal structured state to assume a state that is 
much more disordered (Bloemendal and Jiskoot, 2005).  This transition can be fitted 
to a sigmoidal curve and the midpoint of this curve can be used to determine the 
thermal melting or unfolding temperature of the protein in the sample.  Monitoring 
the thermal transitions of purified IpaC, IpgC and IpaC/IpgC complexes reveal that 
upon complex formation the thermal melting temperature of IpaC and IpgC are 
significantly increased from 45.5 °C to 56.3 °C and 53.9 °C to 56.3 °C (Table 3.2).  
These data further support that chaperone binding strongly influences and increases 
IpaC protein structure and stability. 
 
Scanning Mutagenesis of the IpaC C-terminal Tail  
Previous structure function analyses have revealed key regions within IpaC 
important in secretion, IpgC and IpaB binding, cell signaling and invasion (Picking et 
al., 2001) (Harrington et al., 2003).    More specifically, the 19 most C-terminal 
amino acids of IpaC have been determined to play an important role in invasion and 
actin nucleation (W.D. Picking, unpublished results).  In order to fully characterize 
this region, scanning mutagenesis was performed to identify specific residues 
important in IpaC effector function.  Deletion of this region abolishes the ability of 
the bacterium to invade Henle 407 cells, but does not significantly impact its ability 
lyse sheep erythrocytes (W.L. Picking, B.M. Hoffman, K. Flentie, unpublished data).  
The ability of S. flexneri to lyse red blood cells (contact hemolysis), is indicative of 
IpaBC pore formation and insertion into the plasma membrane of red blood cells 
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(RBC’s) (Clerc et al., 1987) (Hakansson et al., 1996) (Blocker et al., 1996).  
Scanning mutagenesis of this region reveals several residues important for S. flexneri 
invasion within this region, including S345, I346, N347, A354 and I357.  
Substitutions at these amino acids result in a significant loss in invasion (Table 3.3). 
The 19 most C-terminal residues of IpaC and the Salmonella homologue, SipC, are 
relatively well conserved between the two proteins, differing only at five residues 
(Kaniga et al., 1995). Additionally, it has been demonstrated that SipC’s actin 
nucleation function lies within the C-terminal half of the protein, which has recently 
been shown to be true for IpaC (Hayward and Koronakis, 1999) (Kueltzo et al., 
2003).  In order to determine the importance of these unconserved residues in IpaC, 
mutations were made individually to four of the five unconserved residues in IpaC 
(N351A, T353A, A354L, Q356A).  While three of the four mutations did not exhibit 
a significant decrease in invasion individually, alanine substitution at 354 did exhibit 
a 29% decrease in invasion.  To mirror the SipC tail even more closely, double and 
triple substitutions were made at residues 351, 353 and 356.  These mutations also 
resulted in a significant reduction in the invasion phenotype (Table 3.3), suggesting 
that while these residues do not appear to act significantly on an individual basis, they 
may act as a group to facilitate invasion. 
To ensure that these proteins were still being expressed and not degraded by S. 
flexneri, western blot analysis was performed.  Those mutants exhibiting levels of 
invasion 75% or lower than wild type were grown overnight and resulting pellets 
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Mutant 
Name 
345                                     365 Relative Invasion (± SE)a 
IpaC (wt) SINQSKNSTASQIAGNIRA  100 ± 12 
79 AINQSKNSTASQIAGNIRA 23 ± 14 
78 SSNQSKNSTASQIAGNIRA 9 ± 7 
77 SILQSKNSTASQIAGNIRA 73 ± 8 
76 SINLSKNSTASQIAGNIRA 102 ± 5 
75 SINQAKNSTASQIAGNIRA 100 ± 9 
74 SINQSINSTASQIAGNIRA 95 ± 4 
73 SINQSKASTASQIAGNIRA 95 ± 6 
72 SINQSKNATASQIAGNIRA 93 ± 3 
71 SINQSKNSAASQIAGNIRA 93 ± 15 
70 SINQSKNSTLSQIAGNIRA 71 ± 25 
61 SINQSKNSTASAIAGNIRA 101 ± 2 
62 SINQSKNSTASQSAGNIRA 32 ± 15 
63 SINQSKNSTASQISGNIRA 82 ± 38 
64 SINQSKNSTASQIASNIRA 100 ± 10 
82 SINQSKNSTASQIAGQIRA 90 ± 36 
83 SINQSKNSTASQIAGAIRA 99 ± 5 
65                 SINQSKNSTASQIAGNSRA 97 ± 8 
66 SINQSKNSTASQIAGNIRI 99 ± 10 
7161 SINQSKNSAASAIAGNIRA 58 ± 31 
9361 SINQSKASAASAIAGNIRA 29 ± 19 
 
Table 3.3  The effect of scanning mutagenesis on the IpaC C-terminal tail 
Scanning mutagenesis of the 19 amino acid effector region of IpaC.  All mutants in 
the table above have a relative hemolysis of 100% compared to IpaC wild-type (wt).  
a Relative invasion is determined as a percentage to IpaC wild type (W.L. Picking, 
B.M. Hoffman, K. Flentie, unpublished data). 
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 were probed for IpaC using anti-rabbit IpaC antibodies (R66).  All IpaC proteins 
were expressed at levels comparable to wild type S. flexneri (Figure 3.4). 
 
IpaC Does Not Appear to Directly Interact with Cdc42  
It is widely accepted that the small Rho GTPase Cdc42, plays a role in Shigella 
invasion.  It was thus proposed that IpaC may directly interact with Cdc42 to induce 
invasion (Adam et al., 1995, 1996) (Tran Van Nhieu et al., 1999).  In Salmonella 
typhimurium, the IpaC homologue SipC is essential for invasion.  However, it is the 
guanine exchange factor (GEF) SopE2, not SipC, that has been demonstrated to 
interact directly with Cdc42 and direct actin polymerization (Bakshi et al., 2000) 
(Stender et al., 2000).   Interestingly, SopE2 shares absolutely no sequence homology 
with IpaC and there is no known homologue of SopE2 in Shigella.  In order to 
investigate the relationship between IpaC and Cdc42, fluorescence polarization (FP) 
was utilized to assess the ability of these two proteins to interact directly.   
Fluorescence polarization is a form of fluorescence spectroscopy that provides 
a sensitive measure of rotational diffusion of molecules in solution.  In solution, 
molecules move at a rate inversely related to their molecular volume.  Larger 
molecules thus rotate more slowly in solution, while smaller molecules rotate faster 
(Lakowicz, 1983).  Due to the sensitivity of FP, changes in the rotational diffusion 
rate of a fluorescently tagged molecule, upon binding to a nonfluorescent molecule 
can be accurately measured as an increase in FP value.  If a molecule is capable of  
 
 46 
 
 
 
 
 
 
 
 
 
Figure 3.4  Western blot analysis of IpaC C-terminus mutants demonstrating 
poor invasive phenotypes 
To ensure that all IpaC C-terminal mutants were expressing ipaC, Western blots were 
performed on pellets of the IpaC C-terminal mutants demonstrating a relative 
hemolysis of 75% or lower.  IpaB and IpaC mutants at times appear as doublet bands 
upon Western blot analysis. 
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binding to the fluorescently tagged molecule in solution, thereby creating a larger 
complex, the polarization value increases (Lakowicz, 1983).  Using fluorescently 
labeled Cdc42, FP was used to determine the ability of Cdc42 to bind IpaC.  
Increasing amounts of IpaC were titrated with FITC-labeled Cdc42 and the change in 
polarization was measured.  SopE2 binding of FITC-Cdc42 was used as a positive 
control.  Although, SopE2 caused a significant increase in the polarization value (mP) 
of FITC-Cdc42, IpaC did not induce a change in the polarization value of FITC-
Cdc42 (Figure 3.5).  Nanomolar concentrations of SopE2 were enough to cause 
increases in FITC-Cdc42 polarization while, in contrast high concentrations of IpaC 
where unable to induce any change in FITC-Cdc42 polarization.  Nearly identical 
results were obtained when the assay was carried out with FITC-Cdc42 pre-incubated 
with GTP (data not shown).  These data suggest that IpaC does not directly associate 
with Cdc42. 
 
Discussion   
Within the S. flexneri type III secretion system, IpaC has been shown to serve 
multiple functions.  It possesses the ability to disrupt liposomes, promote invasion of 
epithelial cells, bind to its translocator protein partner IpaB and bind to its chaperone 
IpgC (Picking et al., 2001) (Kueltzo et al., 2003).  IpgC association with IpaC 
prevents protein degradation and aggregation within the bacterial cytoplasm and has 
also been proposed to hold IpaC in a secretion competent state (Blocker et al., 1999).  
To date, few data have been obtained describing this association.   
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Figure 3.5  Effect of IpaC binding on the emission of FITC-labeled Cdc42. 
The effect of IpaC and SopE2 on FITC-labeled Cdc42 was determined using 0.5 µM 
of FITC-Cdc42 and increasing concentrations of IpaC and SopE2.  The data shown are 
representative of at least three assays and were obtained with GTP bound to FITC-
Cdc42.    
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 Here we have demonstrated that the IpaC/IpgC complex can be purified from 
an E. coli expression system in a highly soluble and stable state.  Circular dichroism 
spectroscopy data show that upon IpgC binding, the IpaC α-helical content increases 
significantly, while its β-sheet composition decreases.  Additionally, thermal melting 
experiments show an increase in protein melting temperature.  These data suggest that 
IpgC association not only significantly induces conformational changes in IpaC but it 
also stabilizes the protein’s overall structure.   The inner diameter of the needle of the 
S. flexneri TTSA measures approximately 2.5 nm (Blocker et al., 2001) and IpaC 
possesses a relatively large molecular mass (42 kDa).  It would thus be unlikely that 
IpaC could be secreted through the needle in its fully folded state.  To accommodate 
these size restraints, it has been predicted that IpaC must pass through the needle in 
an alternative conformation.  Changes in protein conformation, as detected by circular 
dichroism, support the proposal that IpgC holds IpaC in a secretion competent state 
prior to passage through the needle apparatus.  
In addition to addressing the influence of IpgC binding on IpaC, we also 
investigated the effector function of IpaC.  Deeper investigation into the C-terminus 
of IpaC demonstrated that not only are the 19 most C-terminal amino acids of IpaC 
required for S. flexneri invasion, but specific amino acids appear to play a vital role in 
invasion-related communication with the host cell.  Point mutations at positions 345, 
346, 347, 354 and 357 significantly lower levels of invasion.  Additionally, in 
attempts to make IpaC more like its Salmonella homologue, double and triple 
mutations at residues 351, 353 and 357 resulted in a dramatic decrease in 
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invasiveness.  These results indicate that the 19 amino acid C-terminal tail region 
plays a vital role in bacteria-host cell communication.  We do not yet know how these 
mutations influence the structure of this portion of IpaC.  
As previously described, S. flexneri utilizes type III secretion to induce 
membrane ruffling and cytoskeletal rearrangements within the host cell.  This 
eventually results in entry of the pathogen in a process that visually resembles 
phagocytosis.  In order to facilitate this, effector proteins of the TTSS must utilize cell 
signaling pathways to direct cytoskeleton and membrane components.  It has been 
shown that small Rho GTPases play a significant role in this process, especially 
Cdc42.  Thus, it has been proposed that IpaC interacts directly with Cdc42, though 
how this interaction occurs has yet to be demonstrated (Adam et al., 1995, 1996) 
(Tran Van Nhieu et al., 1999).  Fluorescence polarization data in this Chapter shows 
that IpaC is unable to bind to FITC-labeled Cdc42.  This data demonstrates that IpaC 
does not directly interact with Cdc42 and IpaC’s role in mediating host cytoskeletal 
rearrangements is through a different set of interactions that alter host cell signaling. 
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CHAPTER 4 
Analysis of the IpaBC pore complex 
 
Introduction 
A number of gram-negative pathogens utilize type III secretion systems to 
move effector proteins from the bacterial cytoplasm into the cytoplasm of a host cell.  
Although, the TTSS is a large apparatus composed of 25 or more proteins at various 
copy numbers, many of the proteins are conserved among bacterial genera, 
particularly those associated with the apparatus structure.  Some proteins are 
conserved at the sequence level while others are conserved structurally or 
functionally.  One such conserved structural component in this class of secretion 
systems is the translocon.  Initially, the term translocon was coined to describe sites 
within the endoplasmic reticulum at which protein co-translational translocation 
occurred into the rough endoplasmic reticulum lumen, but today the term has 
broadened to include a number of diverse protein-translocation systems (Schnell and 
Herbert, 2003).  In type III secretion, the translocon is a multiprotein transmembrane 
complex that spans the plasma membrane of the target cell and connects it with the 
type III secretion apparatus of the bacterium.  This protein complex is proposed to 
form a channel through which the type III secretion apparatus is able to inject proteins 
directly into the host cell cytosol (Buttner and Bonas, 2002). 
In bacterial type III secretion, host cell contact induces secretion of effector 
proteins through the needle apparatus to the targeted eukaryotic cell (Harper and 
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Silhavy, 2002).  The first proteins secreted actually insert into the host cell plasma 
membrane to form the pore translocon pore (Blocker et al., 1999).  The translocon 
proteins may have host-altering effector functions of their own, but this is not 
necessarily a universal trait of this class of proteins.  The major role of the pore 
translocation complex is to permit later effectors access to the host cell cytoplasm via 
the TTSS (Blocker et al., 1999).  Because translocon formation is a conserved theme 
throughout type III secretion, pore complexes have been found and are well-studied 
in a number of Gram-negative pathogens including YopBD in Yersinia spp., PopBD 
in P. aeruginosa, EspBD in E. coli, and IpaBC in S. flexneri (Hakansson et al., 1993) 
(Menard et al., 1994b) (Kenny et al., 1996) (Hauser et al., 1998).  
 
The IpaBC tranlocon complex 
Like most other known translocator proteins, IpaB and IpaC both contain 
putative transmembrane regions and are known to associate with membranes in vitro 
(Menard et al., 1994a) (DeGeyter et al., 1997) (DeGeyter et al., 2000).  In the 
absence of the translocator proteins, late effector proteins are not secreted into the 
host cell, though they can be secreted into the bacterial culture supernatant (Menard et 
al., 1994b).  Each translocon component protein has distinct structural and functional 
characteristics.  As mentioned in the Introduction, IpaB has been implicated in 
controlling type III secretion of effector proteins as well as having an effector 
function associated with macrophage apoptosis (Menard et al., 1994b) (Zychlinsky et 
al., 1994).  In contrast, IpaC does not appear to possess regulatory function with 
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regard to type III secretion and is not required for inducing macrophage apoptosis; 
however, IpaC does play an important role as an effector function by promoting 
invasion after directly influencing actin nucleation within targeted cells (Menard et 
al., 1996) (Tran Van Nhieu et al., 1999) (Kueltzo et al., 2003).  How these proteins 
work together is still poorly understood.   
The investigation of translocator component proteins has been done largely on 
IpaB and IpaC as individual proteins.  Although it is generally accepted that the 
IpaBC complex forms a pore in eukaryotic cells, the complex itself has yet to be 
characterized (Menard et al., 1994b) (Blocker et al., 1999).  Here, we show that the 
IpaBC translocon complex can be purified as a soluble complex from S. flexneri.  
Purified complexes were then used to further characterize IpaBC’s interactions with 
artificial phospholipid liposomes and to begin studies on the structural aspects of the 
translocon complex.  This information should be useful in understanding the physical 
nature of translocon complexes from other gram negative bacterial pathogens.  
 
 Results 
Purification of the IpaBC pore complex 
It was discovered by Parsot et al., that in the absence of a target host cell, secretion of 
the type III effector proteins from Shigella flexneri could be induced by the addition 
of the small amphipathic dye Congo red to growing cultures at 37 °C (Parsot et al, 
1995).  After Congo red induction, culture supernatants contain high quantities of the 
effectors IpaA, IpaB, IpaC, IpaD and IpgD.  It has also been determined that other 
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dyes similar in structure to Congo red, including Evan’s blue and brilliant orange, are 
able to induce similar levels of secretion by the Shigella type III secretion machinery 
(Bahrani et al., 1997).  All three molecules are amphipathic and symmetrical 
comprised of two amino-substituted naphthalenesulfonate groups connected by azo 
linkages to a central biphenyl group.  How this molecule interacts with the TTSA is 
unknown. 
Using Congo red induction, the IpaBC translocon can accumulate at 
significant concentrations in bacterial supernatants and purified as a soluble complex 
from S. flexneri.  Because the effector proteins IpaA and IpgD co-purify with but do 
not associate with the IpaBC pore complex, the translocon is expressed from an 
ipaA/ipgD null Shigella flexneri strain (personal observation).  The absence of IpaA 
and IpgD reduces the virulence of the organism somewhat, but the pathogen retains 
its ability to invade cultured cells and to carry out contact mediated hemolysis.  Using 
this strain also permits safer handling of large volume of cultures.  Following Congo 
red induction of ipaA/ipgD S. flexneri, IpaB IpaC and IpaD are secreted 
extracellularly.  The Congo red supernatant is then loaded onto an anion exchange Q-
Sepharose column.  The differently charged proteins (IpaB, IpaC and IpaD) can then 
be separated from the amphipathic Congo red dye by their elution in 1M NaCl.  Once 
the Congo red has been removed from the sample, IpaD can be separated from the 
IpaBC pore complex using gel filtration chromatography (Figure 4.1).  
By comparing the IpaBC complex to gel filtration retention times of known 
proteins the apparent molecular weight of the IpaBC complex can be estimated  
 55 
 
 
 
 
Figure 4.1 Purification of the IpaBC complex from Shigella flexneri 
IpaB, IpaC and IpaD were prepared from an IpaA IpgD null Shigella flexneri 
strain via Congo red induction (the smear between IpaC and IpaD is Congo 
red dye).  Purification of IpaB, IpaC and IpaD through ion exchange 
chromatography.  Purification of IpaB and IpaC from IpaD through gel 
filtration column.  IpaD is not shown after size exclusion chromatography as 
it elutes much later at a molecular weight of 37 kDa. 
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(assuming the complex is globular and spherical in nature).  The IpaBC complex 
migrates at an apparent molecular weight of approximately 190 kDa while free IpaD 
migrates at a molecular weight of 37 kDa.  This migration implies that the IpaBC 
complex is larger than simply one subunit of IpaB (62 kDa) and one subunit of IpaC 
(42 kDa).  Additional work is needed to determine the exact stiochiometry and 
composition of the complex; however, this mass potentially implies a IpaB1:IpaC3 
complex which correlates with the observed band intensities in the bottom part of 
Figure 4.1.  
 
Liposome disruption studies 
As previously mentioned, both IpaB and IpaC possess hydrophobic regions 
that have been speculated to be putative transmembrane regions (Mills et al., 1998).  
Additionally, numerous studies have demonstrated that both IpaB and IpaC delivered 
by Shigella possess the ability to bind to and disrupt red blood cells and liposomes in 
vitro (Clerc et al., 1986).  Modified hemolysis assays in which red blood cells 
(RBC’s) were incubated with Shigella and then the resulting RBC membranes were 
purified on a sucrose gradient and probed with anti-IpaB and anti-IpaC antibodies 
revealed that IpaB and IpaC remain tightly associated with RBC membranes (Blocker 
et al. 1999).  In line with these findings, several studies have demonstrated that both 
IpaB and IpaC have the ability to disrupt and bind artificial membranes in vitro, 
however, there have been no studies to date describing the ability of the IpaBC 
protein complex to bind or disrupt liposomes (DeGeyter et al., 2000) (Kueltzo et al., 
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2003) (Harrington et al., 2003) .  In order to investigate the ability of the IpaBC pore 
to disrupt liposomes in vitro, unilamelar phospholipid liposomes were synthesized.  
These liposomes were composed of 50% DOPC, 50% DOPG and 2% cholesterol to 
very roughly mimic plasma membrane components. In order to monitor liposome 
disruption in solution, the fluorescent molecule sulforhodamine B (SRB) was used as 
a probe.  SRB was chosen for this assay rather than fluorescein because its 
fluorescence intensity is independent of pH in the assays used here.   
In areas of high concentration many fluorphores, including SRB, exhibit a 
significant amount of autoquenching (Mach and Middaugh, 1995).  Thus, 
encapsulating fluorescent molecules at high concentrations limit the amount of 
fluorescence intensity that is detected spectroscopically.   If the barrier confining the 
fluorophore to the high concentration is perturbed, the fluorophores are released into 
the surrounding solution.  Diffusion of the fluorophores into solution results in an 
increase in fluorescence intensity due to their reduced interaction or local 
concentration.  The rate and amount of fluorescence intensity increase are indicative 
of how quickly and efficiently the barrier confining the fluorescent molecules is being 
disrupted (Mach and Middaugh, 2005).  By using liposomes to encapsulate SRB, 
characteristic autoquenching and diffusion priciples can be used to measure the 
ability of proteins to disrupt lipid bilayers.  Whether this occurs by membrane 
disruption or by pore formation is not measured by this assay as described here (A 
method to measure pore formation is described later). 
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Previous work by others in our group has demonstrated that both IpaB and 
IpaC are able to disrupt liposomes in vitro to cause the diffusion of fluorophores into 
solution (Kueltzo et al., 2003) (Harrington et al., 2003). Additionally, when IpaB and 
IpaC are bound to the chaperone IpgC, the ability for these proteins to disrupt the 
liposomes was abolished (Birket et al., 2007).  Here we monitor the ability of the 
IpaBC complex to disrupt liposomes and release fluorophores.  SRB-containing 
liposomes were added to buffer in a quartz cuvette and fluorescence intensity was 
measured for a short period to establish baseline fluorescence in the absence of 
purified protein.  After establishing a baseline, purified proteins or protein complexes 
were added to the liposomes in solution and their abilities to disrupt the liposomes 
was determined by spectroscopically monitoring the increase in fluorescence over 
time.  One percent Trition-X-100 was then added to completely lyse the liposomes 
and give the maximal increase in fluorescence.  As expected, purified IpaB and IpaC 
were able to disrupt liposomes and cause an increase in fluorescence.  Interestingly, 
the rate and total amount of fluorescence increase was greater when the IpaBC 
complex was added rather than either purified IpaB or IpaC.  These data contrast 
liposome disruption data for the IpaC/IpgC and IpaB/IpgC complexes, which appear 
unable to cause liposome distruption (data not shown).   Because equal amounts of 
proteins were added in each case, these data suggest that the IpaBC complex more 
efficiently causes fluorophore release from the liposomes than the individual 
translocator proteins (Figure 4.2). 
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Figure  4.2 Lipid membrane disruption by IpaB, IpaC and IpaBC  
Liposomes containing SRB were incubated with IpaB, IpaC and the IpaBC complex 
and fluorescence was measured over time. Characteristic curves of fluorophore 
release by protein interaction with the liposome.  Each curve is representative of at 
least three different measurements.   
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 Many cell signaling pathways at the plasma cell membrane are localized to 
lipid rafts, which contain elevated amounts of cholesterol and specific classes of 
integral protein membranes.  Because the IpaC component of the IpaBC complex has 
been shown to interact with actin and potentially with Cdc42, it has been proposed 
that the IpaBC translocon localize to lipid rafts due to interactions with cholesterol 
(LaFont et al., 2002) (van der Goot et al., 2004).  IpaB has been shown to possess 
cholesterol binding properties which could help to target the IpaBC complex to lipid 
rafts.   
To determine the effect that cholesterol has on the IpaBC pore function, the 
liposome disruption assays with 50% DOPC:50%DOPG liposomes containing 0% 
cholesterol and 2% cholesterol (each encapsulating SRB) were constructed.  Assays 
were otherwise conducted exactly as described above.  Liposomes containing 
cholesterol showed a more dramatic increase in fluorescence intensity over time 
following the addition of the IpaBC complexes than liposomes lacking cholesterol 
(Figure 4.3).  There are potentially several explanations for this observation.  It is 
possible that the IpaBC complex has a greater affinity for liposomes containing 
cholesterol, resulting in more pore complexes binding the lipsome and thus releasing 
a higher number of fluorophores.  This would be consistent with IpaB’s cholesterol 
binding activity promoting specific interactions with the liposomes.  Alternatively, 
this increased rate of fluorophore release would be caused by the IpaBC complex 
making more intimate contact with the liposomes (more rapid insertion) due to 
membrane structure effects of the cholesterol, resulting in a higher rate of fluorophore  
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Figure  4.3 IpaBC binds preferentially to cholesterol containing 
liposomes. 
Liposomes containing SRB were incubated with the IpaBC complex and 
fluorescence was measured over time.  The rate and amount of 
fluorescence by IpaBC is greater in liposomes containing 2% cholesterol 
(81% release) than liposomes containing no cholesterol (71% release).  
Curves are representative of at least three separate measurements.  
Liposomes in PBS only (no protein) are included as a negative control. 
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release.  Ultimately, it appears that the addition of cholesterol to the lipid mixture 
enhances the IpaBC translocon complex’s ability to disrupt lipid membranes.   
It is important to note that small increases in cholesterol have been observed 
to enhance the translocon’s ability to disrupt liposomes, however, this enhancement 
may have an upper limit.  In liposome disruption assays where liposomes contain 
equal concentrations of DOPC and DOPG and 5% cholesterol IpaBC ability to 
disrupt liposomes is similar to rates of liposomes possessing 2% cholesterol.  In the 
same assay, where liposomes contain 20% cholesterol, lipsome disruption occurs at a 
rate lower than 2% containing liposomes (observation, data not shown).  Additional 
investigation will have to occur to determine if high amounts of cholesterol are 
inhibitory to IpaBC binding, however these later observations may be consistent with 
cholesterol physical effects on the liposomes having influence on the IpaBC complex 
disruption of those liposomes.  Alternatively, at very high cholesterol concentrations, 
it is possible that small amounts of free sterol may be competing with the liposomes 
for binding to IpaB. 
 
Biophysical characterization of the IpaBC pore 
To investigate changes that may have occurred in the IpaB and IpaC 
secondary structure upon IpaBC complex formation, circular dichroism was 
employed to monitor secondary structure of purified IpaB, IpaC and the IpaBC 
complex.  Both far UV spectra and thermal melting spectra of the purified proteins 
show that upon binding to one another, IpaBC complex undergoes a change in 
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secondary structure that coincides with an increase in thermal stability of the proteins 
(Figure 4.4 and Table 4.1).  The incorporation of IpaB and IpaC into IpaBC 
complexes appear to be accompanied by an increase in the α-helical state of the 
proteins.  Thermal stability is monitored by following the CD signal at 222 nm as  
temperature is increased to determine the movement of α-helical structures to a more 
disordered state.  The binding of IpaB and IpaC to each other appears to induce a 
more structured and more stable protein than that of either protein alone (Table 4.1).   
 
Pore Formation 
Previously, Blocker et al. have used osmotic protection assays in conjunction 
with contact-mediated hemolysis assays to estimate the inner diameter of the IpaBC 
translocon complex (Blocker et al., 1999).  Erythrocyte hemolysis assays are 
routinely used to determine the efficiency of translocon formation by S. flexneri in 
RBC membranes (Clerc et al., 1987).   Bacterial cultures are incubated with RBCs 
and then hemolysis is determined by measuring the absorbance of free hemoglobin.  
In this assay, pore formation by the TTSA in the RBC membrane leads to osmotic 
disequilibrium and eventually lysis of the red blood cell.  In order to estimate the 
inner diameter of the pore, osmotic protection assays were carried out by coupling 
hemolysis with the addition of osmoprotectants of various sizes to prevent cell lysis.  
Osmoprotectants larger than 26 Å were able to block the pore and prevent osmotic 
shock and cell lysis, thereby suggesting that this is the approximate size of the 
translocon pore (Blocker et al., 1999).   
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Figure 4.4  Far UV CD spectra of purified IpaB, IpaC and the IpaBC pore. 
Far UV spectra and melting temperatures were monitored by circular dichroism.  CD 
spectra were monitored from 190 nm to 280 nm, while Tm were determined by 
monitoring the transition of spectra at 222 nm from α-helical structure to disordered 
state. 
 65 
Protein Melting Temperature (Tm) ± SE, °C 
IpaB 51.6 ± 0.0 
IpaC 45.5 ± 0.3 
IpaBC 56.7 ± 0.4 
 
Table 4.1 Thermal unfolding temperatures of purified IpaB, IpaC and 
IpaBC complex as monitored by CD. 
Proteins were monitored at 222 nm over increasing temperature to determine 
transitions from α-helical conformations to a state of disorder.   Melting 
temperatures were determined by the midpoint of a fitted sigmoidal curve. 
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 To relate these past findings to the activity of the purified IpaBC complex, an 
alternative approach was taken to determine whether there is pore formation in 
artificial liposomes.  Liposomes were constructued using 25% DOPC:75% DOPG 
and encapsulating fluorescently labeled dextrans with a hydrodynamic radius ranging 
from less than 1.0 nm to approximately 3.5 nm.  Despite their large and varied sizes, 
these molecules also exhibit autoquenching with respect to their fluorescence when 
entrapped at high concentrations in liposomes.  Liposome disruption assays were 
conducted as previously described above and fluorescence intensity was again 
measured spectroscopically (Figure 4.5).  Those liposomes containing dextrans of a 
hydrodynamic radius of 2.2 nm or less released the highest amounts of fluorescence 
(25-28%) while those with a hydrodynamic radius of 3.5 nm released significantly 
less fluorescence (8%) suggesting the pore has an upper limit between 2.2 nm and 3.5 
nm (A.H. Harrington, unpublished data).  These data are consistent with previous 
estimations of pore inner diameter and they show the IpaBC complex can form pores 
in liposomes in vitro (Harrington et al., 2005). 
To further determine the physical dimensions of the pore complex, purified 
IpaBC complexes were sent to Dr. Stefan Bossmann at Kansas State University to 
analyze using atomic force microscopy (AFM).  Dr. Bossman’s current work includes 
pore formation by the Mycobacterium smegmatis porin, MspA.  AFM is a scanning 
probe microscopy method capable of resolution at the nanometer scale.   
IpaBC protein samples were spin-coated onto P(NIPAM/Acrylic acid) coated 
chips and were then imaged through “tapping mode.”  As the canteliver and tip are  
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Figure  4.5 IpaBC pore formation is reflected through size exclusion. 
Three different sized dextrans were encapsulated in liposome bilayers and incubated 
with equal concentrations of IpaBC complex.  Three kDa dextrans have a 
hydrodynamic diameter of less than 1 nm and release 28% of dextrans.  Ten kDa 
dextrans have a hydrodynamic diameter of 1.8 to 2.2 nm and release 22% of dextrans, 
while 40 kDa dextrans have a diameter of approximately 3.5 nm and release 8% 
dextrans (A.H. Harrington, unpublished data). 
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tapped across the sample they are able to provide a topographical picture of the 
slide’s surface (Engel, 2002).  AFM data received from Dr. Bossmann show that 
IpaBC complex is consistently uniform in size (Figure 4.6 and Figure 4.7).  Perhaps 
more importantly, the IpaBC complex forms pores within the acrylamide coating with 
a corrected inner diameter of 3.5 nm ± 0.5 nm.  The outer diameter of the pore 
complex was also determined to be 13.5 nm ± 1.5 nm (data not shown).  These data 
correlate well with the liposome studies previously shown in this Chapter for inner 
pore diameter in addition to unpublished dynamic light scattering data for the pore’s 
outer diameter (W.D. Picking, unpublished data).  
 
Discussion 
Unlike most of the proteins from the S. flexneri TTSS studied in our lab, we 
purify the IpaBC complex from the pathogen rather than producing recombinant 
protein in E. coli.  Because we can purify the protein from its native environment, it is 
more likely to form a native complex.  Utilizing the small molecule dye Congo red, 
we can mimic host cell interaction and induce the secretion of effector proteins into 
the extracellular milleu.  By using an ipaA/ipgD null S. flexneri strain, we can 
effectively purify soluble IpaBC translocon complex for detailed study. 
Circular dichorism data show that binding of the translocator proteins to each 
other results in an increased state of protein organization.  This conformational effect 
probably is more associated with IpaC since it has a high degree of unstructured 
component when alone in solution.  The thermal melting temperature of the IpaBC 
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Figure 4.6 Atomic force microscopy of the IpaBC pore complex. 
IpaBC complexes were spin-coated into acrylamide coated slides and 
measurements were taken using atomic force microscopy.  Horizontal cross-
sections were measured through “tapping” methods across the surface of the 
slide (green line).  Images were taken at a resolution of 400 nm.  Images are 
courtesy of Dr. Stefan Bossmann, University of Kansas. 
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Figure 4.7  Additional AFM images depicting IpaBC complexes. 
The AFM figures above depict IpaBCprotein complexes of similar sizes 
and shapes.  A. Image at 800 nm, image on the left is raw data while image 
on the right is refined.  B.  Pore complexes imaged at 6250 nm, left image 
is raw data, while the right frame is refined. 
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complex is higher than either IpaB or IpaC alone, suggesting that upon translocon 
formation, the protein components are stabilized.  As previously demonstrated, and 
similar to other type III translocator proteins such as PopB and PopD in Pseudomonas 
aeruginosa and YopB and YopD in Yersinia spp., the IpaB and IpaC proteins are 
capable of individually interacting with phospholipid membranes.  Here we show that 
not only is the IpaBC complex also capable of this interaction, but it also appears that 
this interaction is enhanced for the IpaBC complex relative to IpaB and IpaC 
individually.  These data correlate with CD spectroscopic analyses, strengthening the 
proposal that upon IpaBC binding the two proteins undergo a conformational change 
that enhances membrane binding function and protein stability.  This change may be 
related to function.   
It has been well documented that lipid rafts play an important role in cell 
signaling processes.  Efficient invasion by in Salmonella and Shigella has been shown 
to require the presence of cholesterol.  It has also been demonstrated that IpaB is a 
cholesterol binding protein.  With this in mind, it could be deduced that cholesterol 
plays an important role in translocon insertion into the host cell membrane.  Our 
liposome assays show that not only does the IpaBC complex bind to cholesterol-
containing liposomes, but the IpaBC complex may have a greater affinity for 
membranes containing cholesterol or that cholesterol may induce a conformational 
change in the IpaBC complex that allows the complex to insert more efficiently into 
membrane bilayers.  The ability for IpaB to behave as a cholesterol binding protein 
makes it attractive to speculate that this activity increases the affinity for the IpaBC 
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complex for liposomes that have a cholesterol component.  Interestingly, very high 
concentrations of cholesterol seemed to reverse this trend. 
Circular dichroism shows that the Shigella IpaBC complex contains a high 
degree of α-helicity and that the pore complex is more thermally stable than either 
protein alone.  Biophysical analyses also provided insight into the structural 
dimensions of the IpaBC complex.  Liposome assays suggest that the inner diameter 
of the IpaBC complex has an upper limit of over 2.2 nm but well under 3.5 nm.  
Supporting data were obtained from AFM analyses.   
The data presented here touch on some of the biophysical aspects of the 
IpaBC translocon but there are still a number of aspects of the S. flexneri translocon 
that warrant investigation.  To date, there the exact stoichiometry and subunit 
composition of the IpaBC complex are unknown.  Additional biophysical methods 
such as dynamic light scattering and ultracentrifugation could be used to investigate 
some of the structural unknowns that remain for the IpaBC complex. 
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CHAPTER 5 
Tyrptophan Scanning Mutagenesis of IpaB 
 
Introduction 
IpaB and IpgC interactions 
As described in Chapters 1 and 4, IpaB is a large effector molecule that is part 
of the Shigella flexneri type III secretion system.  IpaB possesses distinct functional 
roles within Shigella type III secretion, including the ability to direct apoptosis in 
macrophages, bind and insert into lipid membranes and, with IpaC, form a translocon 
complex that inserts as a pore into targeted host cell membranes to direct the entry of 
other effector proteins into the host cell cytoplasm (Menard et al., 1994b) (Zychlinsky 
et al., 1994) (Blocker et al., 1999) .  Due to IpaB’s large molecular size (62 kDa) and 
hydrophobicity, structural information of the protein is limited.  Based on secondary 
structure and structure-function analyses several key regions of IpaB have been 
described (Figure 5.1).  IpaB possesses a N-terminal coil, a hydrophobic putative 
transmembrane region and a predicted large C-terminal coil.  Structure function 
analyses by Guichon et al., have determined that large deletions within the N-
terminus resulted in loss of protein expression; while large deletion mutantions within 
the C-terminus of IpaB were expressed, but invasion, cell cytotoxicity and 
phagosomal escape were diminished or abolished.  Additionally, most small internal 
deletions within the putative transmembrane region resulted in protein function 
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1     MHNVSTTTTG FPLAKILAST ELGDNTIQAA NDAANKLFSL TIADLTANQN INTTNAHSTS 
61   NILIPELKAP KSLNASSQLT LLIGNLIQIL GEKSLTALTN KITAWKSQQQ ARQQKNLEFS 
121 DKINTLLSET EGWTRDYEKQ INKLKNADSK IKDLENKINQ IQTRLSELDP ESPEKKKLSR 
181 EEIQLTIKKD AAVKDRTLIE QKTLSIHSKL TDKSMQLEKE IDSFSAFSNT ASAEQLSTQQ 
241 KSLTGLASVT QLMATFIQLV GKNNEESLKN DLALFQSLQE SRKTEMERKS DEYAAEVRKA 
301 EELNRVMGCV GKILGALLTI VSVVAAAWSG GASLALAAVG LALMVTDAIV QAATGNSFME 
361 QALNPIMKAV IEPLIKLLSD AFTKMLEGLG VDSKKAKMIG SWLGAIAGAL VLVAAVVLVA 
421 TVGKQAAAKL AENIGKIIGK TLTDLIPKFL KNFSSQLDDL ITNAVARLNK FLGAAGDEVI 
481 SKQIISTHLN QAVLLGESVN SATQAGGSVA SAVFQNSAST NLADLTLSKY QVEQLSKYIS 
541 EAIEKFGQLQ EVIADLLASM SNSQANRTDV AKAWLQQTTA 
N-terminal domain
N-terminal coil
Hydrophobic/transmembrane domain
C-terminal coil
 
Figure 5.1 Schematic diagram of regions within IpaB.   
Residues 1-130 are the N-terminus, while residues 130-170 are predicted to be 
an N-terminal coil.  Residues 310-420 are hydrophobic domains.  Amino acids 
540-580 make up a C-terminal coil. 
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similar to wild type (Guichon et al., 2001).  There were two exceptions to this, 
including a deletion encompassing the seven residues before, and three residues 
within, the transmembrane region ( amino acids 307-313) and alternatively, a deletion 
of amino acids 410-417 from the transmembrane region (Guichon et al., 2001).  The 
mutant lacking amino acids 307-316 was expressed similarly to wild-type levels, 
while the mutant lacking residues 410-417 was poorly expressed in Shigella (Guichon 
et al., 2001).  This suggests that the transmembrane region of IpaB may serve 
multiple functions in type III secretion. 
Prior to secretion by the TTSS, IpaB resides in the bacterial cytoplasm bound 
to the chaperone IpgC (Menard et al., 1994b).  Chapters 1 and 3 describe the 
importance of IpgC’s role in S. flexneri type III secretion.  IpgC is a class II 
chaperone that associates individually with IpaB and IpaC, performing several 
functions within the type III secretion system of Shigella flexneri.  IpgC’s association 
with IpaB and IpaC prevents premature association of IpaB with IpaC which would 
result in degradation of the translocator components within the bacterial cytoplasm.  
IpgC is also proposed to hold IpaB in a secretion competent state for passage through 
the needle apparatus of the TTSS (Page et al., 1999).   
Little research has been devoted to understanding the IpaB/IpgC interaction or 
the structural influences these proteins impart on each other.  In this Chapter, we 
investigate the influence of IpgC binding on IpaB using spectroscopic techniques.  
Members of our lab have previously used tryptophan scanning mutagenesis as an 
efficient tool to determine how different regions of IpaC are influenced by IpgC 
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binding.   Here we have initiated use of the same technique to determine regions of 
IpaB influenced by IpgC binding. 
 
Results 
Strain Construction and Protein Purification 
Previous work by Harrington et al. and Birket et al. utilized Trp scanning 
mutagenesis to determine how liposome and IpgC binding influenced the structure 
and the microenvironment of different IpaC regions (Harrington et al, 2005) (Birket 
et al., 2007).  Because of the intrinsic environmental sensitivity of the indole group of 
tryptophan, Trp scanning mutagenesis can be a practical tool for probing the local 
environment of Trp residues in single-Trp containing proteins.  Trp fluorescence is 
directly influenced by the polarity of its surroundings and can be used to determine 
changes influenced by protein binding.   
In order to accurately characterize proteins using tryptophan fluorescence, 
proteins must only carry a single Trp residue.  In previous Trp scanning mutagenesis 
experiments, key IpaC residues were mutated to Trp to construct a library of single-
Trp containing IpaC mutants.  Because wild-type IpaC does not possess a natural Trp 
residue, point mutations were easily made to strategic regions of IpaC.  In contrast, 
wild-type IpaB contains a single Trp residue at position 105 (Figure 5.2).  
Conveniently, this natural Trp residue can be used to characterize the N-terminal 
region of IpaB; however, to create subsequent IpaB single-Trp mutants this residue 
had to first be removed.  IpaB Trp mutants were thus constructed by creating first a  
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N-terminal domain
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1                             130      170                     313                  423          540      580
W105F L133W F328W I402W I578W
 
 
Figure 5.2  Position of tryptophan mutations within IpaB. 
A natural Trp residue is located at position 105.  In order to make single Trp-
containing mutants all mutants were constructed by replacing the natural Trp at 
105 with Phe and then used as a template to construct subsequent Trp mutations 
located at positions 133, 328, 402 or 574.  Key structural or functional regions 
are highlighted. 
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Trp knockout mutant in which W105 was converted to a phenyalanine.  This 
knockout was then used as a template to create additional Trp-containing IpaB 
mutants.   
To characterize regions of IpaB influenced by IpgC binding, several key 
regions were chosen at which new Trp residues could be introduced: position 133 in 
the predicted N-terminal coil; positions 328 and 402 in the hydrophobic/putative 
transmembrane domain; and at position 574 in the putative N-terminal coil (Figure 
5.2).  The primers used are given in Table 5.1.  All the Trp mutants were generated 
using the point mutation W105F so that all mutants contained a single Trp residue, 
resulting in double mutants containing W105F and a single-Trp mutation.  The 
removal of the natural Trp at 105 had no effect on IpaB invasion or hemolysis (Table 
5.2).   
IpaB Trp mutants were created utilizing site-directed mutagenesis (Picking et 
al., 1996).  Primers used to construct Trp mutants are listed in Chapter 1 as Table 2.1 
and here as Table 5.1.  Hydrophobic amino acids with bulky sidechains, such as 
leucine and isoleucine, were targeted for Trp mutagenesis to minimize changes to 
protein structure that might reduce IpaB function. 
Like IpaC/IpgC, IpaB can be purified as a soluble complex with IpgC.   IpaB 
mutants were co-expressed with His-tagged IpgC and recombinant proteins were 
initially purified from Tuner (DE3) E. coli using Ni+ affinity chromatography.  Peak 
fractions were pooled and the resulting IpaB/IpgC complex was seperated from free 
IpgC by size-exclusion chromatography.  In contrast to the IpaC/IpgC complex,  
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Mutant Primer 
Names 
Sequence (3’-5’) 
B50f GAGAGAGAGATTTAAATCCCAGCAACAGGCAAG  
W105F 
B51r GAGAGAGAGATTTAAATGCAGTAATTTTATTTGTTAATG 
B53f GAGAGAGAGACGCGTGACTATGAAAAACAAATTAATAA  
L133Wa 
B54r GAGAGAGAGACGCGTCCATCCTTCAGTTTCAGATAGAA 
B57f GAGAGAGAGGCCGCTTGGTCTGGAGGAGCCTCTCTA  
F328Wa 
B58r GAGAGAGAGGCGGCCGCAACAACACTAACGATAGT 
B59f  GAGAGAGAGGCCGGCGCTCTTGTCCTAGTT  
I402Wa 
B60r GAGAGAGAGGCCGGCGATTGCCCCCAGCCAAGAGCCAATCTATTTGGCTT
B61f GAGAGAGAGCTGCAGCAAACTACTGCTTGAGGC  
I574Wa 
B62r GAGAGAGAGCTGCAGCCATGCTTTGCAACATCAGTT 
 
Table 5.1 Table of primers for IpaB tryptophan scanning mutants 
aMutations after 105 are double mutants containing W105F and the indicated mutation. 
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IpaB/IpgC cannot be separated by lowering the solution pH, suggesting a different set 
of molecular interactions involved in this chaperone binding event.  Previous work by 
Hume et al. has determined that detergent can be used to purify IpaB from E. coli, in 
the absence of IpgC (Hume et al., 2003).  The IpaB/IpgC complex was therefore 
incubated with 2% n-octyl-poly-oxyethylene (OPOE) detergent, which was found to 
release the IpaB from IpgC.  The proteins were then separated using Ni+ affinity 
chromatography where IpaB elutes in the flow through while His-tagged IpgC and 
remaining IpaB/IpgC complexes are bound to the column (Figure 5.3). 
 
IpaB Tryptophan Mutant Characterization 
Most of the Trp mutations introduced here resulted in little change in protein 
thermal stability, or the secretion, invasivness or hemolytic activity of the mutant 
IpaB when it is made in S. flexneri ipaB null strain, SF620 (Tables 5.2 and 5.3).  
Interestingly, the two Trp mutations made within the hydrophobic/transmembrane 
region of IpaB appear to behave differently from one another.  When made in SF620, 
IpaB possessing the F328W mutation appeared to retain wild-type function, while 
I402W, which is also found in the transmembrane region, appears to lose its ability to 
invade Henle 407 cells and is no longer hemolytic.  Additionally, ipaB is expressed at 
reduced quantities in the I402W mutant (Figure 5.3).  Expression levels of ipaB and 
ipgC all IpaB Trp mutants are represented in Figure 5.3. 
Because CD spectroscopy provides data about global secondary structure, one 
would predict that the values in Table 5.3 would provide the same thermal unfolding 
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temperature unless a point mutation had a significant effect on overall protein 
structure.  Thermal melting temperatures of these proteins range from 59.2 ºC to 64.2 
ºC.  Although values in Table 5.3 are relatively close to each other, additional CD 
measurements would be needed to confirm these data.  Further melts involving Trp 
fluorescence would be able to provide local information since Trp fluorescence is 
influenced by local environment rather than global protein structure.   
 
 
 
 
Figure 5.3  Expression and protein purification of IpaB Trp mutations. 
A.  IpaB Trp mutants were co-expressed in E. coli with His-tagged IpgC.  Proteins 
were purified through affinity chromatography.  Free IpgC was separated from the 
complex through size exclusion chromatography (not shown). 
B.  IpaB/IpgC complexes were separated by incubating with OPOE and then were 
loaded onto an Ni+ affinity column.  Free IpaB eluted in the flow through fractions 
while remaining IpaB/IpgC complexes and free IpgC eluted in 1M imidazole (not 
shown). 
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Mutant Relative Hemolysis (%) ± SD Relative Invasion (%) 
± SD 
IpaB (wt) 100 100 
W105F 95 ± 15 89 ± 8 
W105F/L133W 94 ± 9 83 ± 20 
W105F/F328W 103 ± 12 86 ± 8 
W105F/I402W 1 ± 0 1 ± 0 
W105F/I574W 105 ± 14 77 ± 4 
 
 
Table 5.2  Relative invasion and hemolysis of IpaB Trp mutants. 
Invasion and hemolysis are relative to IpaB complement Shigella flexneri strains. 
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Proteina  Melting Temperature (Tm), °C  IpaB/IpgC 
complexes 
 IpaB (wt) 64.1 
W105F/L133W 59.2 
W105F/F328W 62.9 
W105F/I402W TBD 
W105F/I574W 64.2 
 
 
Table 5.3 Thermal melting temperatures of purified IpaB and IpaB Trp 
mutants.  
aMelting temperature for IpaB varies in this Chapter than previously reported in 
Chapter four.  Thermal unfolding was monitored on a different CD instrument and 
may account for variation, all IpaB Trp mutants were measured at the same time as 
the above IpaB on the same instrument.  Melting temperatures are an average of at 
least three spectra. 
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Acquisition of Tryptophan Emission 
In order to determine the polarity of the microenvironment of the Trp residues 
in IpaB, fluorescence emission maxima were determined for each purified single-Trp 
containing IpaB/IpgC complex and the corresponding free form of the IpaB mutant.  
Trp residues were excited at a wavelength of 290 nm and Trp emission maxima were 
determined using a scanning fluorescence spectrophotometer.  Trp emission maxima 
that shift to a shorter wavelength (blue shift) upon IpaB binding to IpgC suggest 
movement of that Trp residue into a more nonpolar environment.  Movement of 
emission maxima to a longer wavelength (red shift), are indicative of movement into 
a more polar environment (Mach and Middaugh, 1995).  The acquisition of 
trypyophan fluorescence maxima is still in progress.  Preliminary results show that 
most complexes exhibit significant red shifts upon IpgC binding, suggesting that IpgC 
does influence changes in the local environment in key regions of IpaB (Table 5.4 
and data not shown).  A red shift upon IpgC binding indicates movement of the Trp 
residues into a more polar environment, meaning the Trp residues are more exposed 
to the surrounding solvent or the protein may be in a more unfolded state when bound 
to IpgC.  More work on these experiments will have to continue to fully and 
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accurately characterize the influences of IpgC binding on IpaB residues at positions 
105, 133, 328 and 574.  Because of poor protein expression levels of the I402W 
mutant, additional experiments will not be continued for this protein.  
 
 
 
 
 
 
Protein Emission maximum 
(Em), nm with 
chaperone IpgC 
Emission maximum 
(Em), nm without 
chaperone IpgC 
Change in 
emission 
maximum 
(∆Em), nm with 
chaperone IpgC 
IpaB TBD TBD TBD 
W105W/L133W 341.0 337.1 + 3.6 
W105W/F328W 332.0 TBD TBD 
W105W/I402W TBD TBD TBD 
W105W/I574W TBD TBD TBD 
 
 
Table 5.4 Tryptophan fluorescence emission maxima for IpaB Trp mutants. 
Purified IpaB and IpaB/IpgC complexes were excited at 290 nm and emission maxima 
were determined spectroscopically.  TBD, to be determined. 
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Discussion and Future Plans 
Trp scanning mutagenesis has provided a useful tool in determining regions of 
IpaC influenced by association with IpgC and liposomes.  In this study we are usin 
the same technique to investigate how regions of IpaB are influenced by chaperone 
binding as well.  Single Trp mutants of IpaB displayed relatively little change in the 
phenotype when made in Shigella with the exception of the substitution of Trp for Ile 
at position 402 in the hydrophobic putative transmembrane region of IpaB.  The 
presence of IpgC in I402W protein purification suggests that IpaB is expressed, 
because in the absence of IpaB being made IpgC must be recovered from inclusion 
bodies rather than the bacterial cytoplasm.  If IpaB had not been made at all, IpgC 
recovery would require an alternative means of purification (personal observation).  
In contrast, a similar mutation to the hydrophobic region (F328W) had little impact 
the phenotype of the protein.  As mentioned earlier in this Chapter, previous structure 
function mutational analyses revealed that small deletions in the of the first half of the 
putative transmembrane domain (including 328) has little impact on the function of 
the protein, as compared to wild type, while deletion within the second half of the 
putative transmembrane region resulted in poor expression of the protein (Guichon et 
al., 2001).  This would be consistent with our observation that the I402W mutation 
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may destabilize IpaB, however, in our case there has not been a deletion introduced 
but rather a substitution.   
If IpaB is misfolded and only able to transiently associate with IpgC, it may 
be quickly targeted for degradation in the Shigella and/or E. coli cytoplasm.   This, 
taken together with data previously reported on IpaB stability, suggests that the 
transmembrane region plays a significant role in IpgC binding and/or IpaB structural 
stability.  It is possible that the I402W mutation disrupts the chaperone binding, thus 
targeting IpaB for degradation.  Alternatively, the I402W mutation may result in 
structural changes that prevent proper folding of IpaB.   
Initial findings suggest that residues 105, 133, 328 and 574 are influenced by 
IpgC binding (preliminary data, not shown).  These areas of IpaB appear to be red 
shifted upon IpgC binding suggesting movement of the Trp residues into a more polar 
environment.  This would suggest that IpgC somehow increases the exposure of these 
residues to the surrounding solution, possibly by holding IpaB in a more unfolded 
state.  As previously stated, IpaB possess the ability to bind to IpgC, IpaC and 
liposomes.  It is evident that IpgC works to prevent key binding regions of IpaB from 
prematurely associating with IpaC and from associating with the interior face of the 
bacterial plasma membrane.  To determine whether IpgC physically wraps around 
key regions of IpaB and/or induces conformational changes that prevent exposure of 
these IpaB regions to the surrounding solution will require additional investigation. 
The above work has demonstrated that like IpaC, a library of IpaB tryptophan 
mutants can be constructed to determine the influence of binding partners on IpaB 
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structure or to determine which regions of IpaB are involved in these interactions.  
The majority of these tryptophan mutations resulted in the purification of soluble 
IpaB/IpgC complexes and did not significantly affect IpaB structure, pore formation 
or epithelial cell invasion.  Future work in this area will include finishing 
characterization of the Trp emission from the introduced IpaB Trp mutants.  
Additional mutants could be made and added to the library to more closely examine 
IpaB structure and function.  Previous work by members of our lab has used IpaC Trp 
mutants to characterize liposome interactions with IpaC in addition to IpaC/IpgC 
binding.  Because IpaB also possess the ability to bind liposomes, the IpaB Trp 
mutants could be used to monitor these interactions as previously described by 
Harrington et al.   
Local structural changes in the IpaB could also be determined using IpaB Trp 
mutants.  Unlike CD spectroscopy, which monitors global secondary structure, 
fluorescence spectroscopy can be used to monitor secondary structure in the local 
environment of the Trp residues (Birket et al., 2007).  Fluorescence intensity spectra 
can be used to monitor the stability of a specific region of IpaB rather than the entire 
protein, more accurately describing the types of effects that binding has upon IpaB.  
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